    introduction_prompt = f'Information: """{context}"""\n\n' \
        f'Using the above information, answer the following' \
        f' query or task: "{question}" in a detailed report --' \
        " The report should focus on the answer to the query, should be well structured, informative ,in depth and comprehensive" \
        "You should strive to write the report as long as you can using all relevant and necessary information provided.\n" \
        f"You MUST write the report in {report_format} format.\n " \
        "Please write the following section based on the above:\n" \
        "Introduction(1500 words) \n" \
        "-Introduce the background, importance, purpose and scope of the research topic.\n" \
        "-Determine the scope of the research and explain why the topic deserves attention \n " \
        "You MUST determine your own concrete and valid opinion based on the given information. Do NOT deter to general and meaningless conclusions.\n" \
        f"You MUST write all used source urls at the end of the report as references, and make sure to not add duplicated sources, but only one reference for each.\n" \
        f"Cite search results using inline notations. Only cite the most relevant results that answer the query accurately. Place these citations at the end \
        of the sentence or paragraph that reference them.\n" \


    prompt= f'Information: """{context}"""\n\n' \
        f'Using the above information, answer the following' \
        f' query or task: "{question}" in a detailed report --' \
        " The report should focus on the answer to the query, should be well structured, informative ,in depth and comprehensive" \
        "You should strive to write the report as long as you can using all relevant and necessary information provided.\n" \
        f"You MUST write the report in {report_format} format.\n " \
        "Please plan this academic report according to the following structure:\n" \
        "一. Introduction(1500 words) \n" \
        "-Introduce the background, importance, purpose and scope of the research topic.\n" \
        "-Determine the scope of the research and explain why the topic deserves attention \n " \
        "二. Literature Review(3000 words) \n" \
        "-A detailed review and discussion of the literature mentioned in the above information, including experimental methods, experimental settings, experimental results, etc.\n" \
        "-Analyze the trends, successes and shortcomings of existing research, which may include comparisons of theories, methodologies or findings.\n" \
        "三. Discussion (3000 words) \n" \
        "-Synthesize the information in the literature review and point out the interrelationships, trends and potential contradictions between studies.\n" \
        "-Discuss unresolved problems, research gaps and future research directions in the research field.\n" \
        "-Synthesize the information in the literature review and propose a scientific method to solve the research problem. Your method should be clear, innovative, rigorous, effective and generalizable. This will be based on a deep understanding of the research problem, its principles, existing research and various entities.\n" \
        "四. Conclusion(800 words)\n " \
        "-Summarize the main findings of the review and the main points of the discussion.\n\n" \
        "You MUST determine your own concrete and valid opinion based on the given information. Do NOT deter to general and meaningless conclusions.\n" \
        f"You MUST write all used source urls at the end of the report as references, and make sure to not add duplicated sources, but only one reference for each.\n" \
        f"Cite search results using inline notations. Only cite the most \
        relevant results that answer the query accurately. Place these citations at the end \
        of the sentence or paragraph that reference them.\n"\

    discussion_prompt =  f'Information: """{context}"""\n\n' \
        f'Using the above information, answer the following' \
        f' query or task: "{question}" in a detailed report --' \
        " The report should focus on the answer to the query, should be well structured, informative ,in depth and comprehensive" \
        "You should strive to write the report as long as you can using all relevant and necessary information provided.\n" \
        f"You MUST write the report in {report_format} format.\n " \
        "Please write the following section based on the above:\n" \
        "Discussion (3000 words) \n" \
        "-Synthesize the information in the literature review and point out the interrelationships, trends and potential contradictions between studies.\n" \
        "-Discuss unresolved problems, research gaps and future research directions in the research field.\n" \
        "-Synthesize the information in the literature review and propose a scientific method to solve the research problem. Your method should be clear, innovative, rigorous, effective and generalizable. This will be based on a deep understanding of the research problem, its principles, existing research and various entities.\n" \
        "You MUST determine your own concrete and valid opinion based on the given information. Do NOT deter to general and meaningless conclusions.\n" \
        f"You MUST write all used source urls at the end of the report as references, and make sure to not add duplicated sources, but only one reference for each.\n" \
        f"Cite search results using inline notations. Only cite the most relevant results that answer the query accurately. Place these citations at the end \
        of the sentence or paragraph that reference them.\n" \



            literature_prompt = f'Information: """{context}"""\n\n' \
        f'Using the above information, answer the following' \
        f' query or task: "{question}" in a detailed report --' \
        " The report should focus on the answer to the query, should be well structured, informative ,in depth and comprehensive" \
        "You should strive to write the report as long as you can using all relevant and necessary information provided.\n" \
        f"You MUST write the report in {report_format} format.\n " \
        "Please write the following section based on the above:\n" \
        "Literature Review(3000 words) \n" \
        "-A detailed review and discussion of the literature mentioned in the above information, including experimental methods, experimental settings, experimental results, etc.\n" \
        "-Analyze the trends, successes and shortcomings of existing research, which may include comparisons of theories, methodologies or findings.\n" \
        "You MUST determine your own concrete and valid opinion based on the given information. Do NOT deter to general and meaningless conclusions.\n" \
        f"You MUST write all used source urls at the end of the report as references, and make sure to not add duplicated sources, but only one reference for each.\n" \
        f"Cite search results using inline notations. Only cite the most relevant results that answer the query accurately. Place these citations at the end \
        of the sentence or paragraph that reference them.\n" \





            conclusion_prompt = f'Information: """{context}"""\n\n' \
        f'Using the above information, answer the following' \
        f' query or task: "{question}" in a detailed report --' \
        " The report should focus on the answer to the query, should be well structured, informative ,in depth and comprehensive" \
        "You should strive to write the report as long as you can using all relevant and necessary information provided.\n" \
        f"You MUST write the report in {report_format} format.\n " \
        "Please write the following section based on the above:\n" \
        "Conclusion(800 words)\n " \
       "-Please summarize based on all of the above.\n\n" \
        "You MUST determine your own concrete and valid opinion based on the given information. Do NOT deter to general and meaningless conclusions.\n" \
        f"You MUST write all used source urls at the end of the report as references, and make sure to not add duplicated sources, but only one reference for each.\n" \
        f"Cite search results using inline notations. Only cite the most relevant results that answer the query accurately. Place these citations at the end \
        of the sentence or paragraph that reference them.\n" \


"""

[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 1', 'font_size': 8.0}, {'text': 'OPEN ACCESS', 'font_size': 7.0}, {'text': 'EDITED BY', 'font_size': 5.5}, {'text': 'Marie Billaud,', 'font_size': 7.0}, {'text': 'Department of Surgery, Brigham', 'font_size': 7.0}, {'text': 'and Women’s Hospital and Harvard', 'font_size': 7.0}, {'text': 'Medical School, United States', 'font_size': 7.0}, {'text': 'REVIEWED BY', 'font_size': 5.5}, {'text': 'Marie-José Goumans,', 'font_size': 7.0}, {'text': 'Leiden University Medical Center', 'font_size': 7.0}, {'text': '(LUMC), Netherlands', 'font_size': 7.0}, {'text': 'Alexander Fletcher,', 'font_size': 7.0}, {'text': 'University of Glasgow, United Kingdom', 'font_size': 7.0}, {'text': '*CORRESPONDENCE', 'font_size': 5.5}, {'text': 'Nimrat Grewal', 'font_size': 7.0}, {'text': 'n.grewal@lumc.nl', 'font_size': 7.0}, {'text': 'SPECIALTY SECTION', 'font_size': 5.499999999999943}, {'text': 'This article was submitted to', 'font_size': 7.0}, {'text': 'Heart Valve Disease,', 'font_size': 7.0}, {'text': 'a section of the journal', 'font_size': 7.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': 'RECEIVED 31 August 2022', 'font_size': 6.4}, {'text': 'ACCEPTED 20 December 2022', 'font_size': 6.454545454545454}, {'text': 'PUBLISHED 09 January 2023', 'font_size': 6.386363636363637}, {'text': 'CITATION', 'font_size': 5.5}, {'text': 'Grewal N, Dolmaci O, Jansen E,', 'font_size': 7.0}, {'text': 'Klautz R, Driessen A, Lindeman J and', 'font_size': 7.0}, {'text': 'Poelmann RE (2023) Are acute type', 'font_size': 7.0}, {'text': 'A aortic dissections atherosclerotic?', 'font_size': 7.0}, {'text': 'Front. Cardiovasc. Med. 9:1032755.', 'font_size': 7.0}, {'text': 'doi: 10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'COPYRIGHT', 'font_size': 5.5}, {'text': '© 2023 Grewal, Dolmaci, Jansen,', 'font_size': 7.0}, {'text': 'Klautz, Driessen, Lindeman and', 'font_size': 7.0}, {'text': 'Poelmann. This is an open-access', 'font_size': 7.0}, {'text': 'article distributed under the terms of', 'font_size': 7.0}, {'text': 'the Creative Commons Attribution', 'font_size': 7.0}, {'text': 'License (CC BY). The use, distribution', 'font_size': 7.0}, {'text': 'or reproduction in other forums is', 'font_size': 7.0}, {'text': 'permitted, provided the original', 'font_size': 7.0}, {'text': 'author(s) and the copyright owner(s)', 'font_size': 7.0}, {'text': 'are credited and that the original', 'font_size': 7.0}, {'text': 'publication in this journal is cited, in', 'font_size': 7.0}, {'text': 'accordance with accepted academic', 'font_size': 7.000000000000028}, {'text': 'practice. No use, distribution or', 'font_size': 7.0}, {'text': 'reproduction is permitted which does', 'font_size': 7.0}, {'text': 'not comply with these terms.', 'font_size': 7.0}, {'text': 'TYPE Original Research', 'font_size': 6.7}, {'text': 'PUBLISHED  09 January 2023', 'font_size': 6.386363636363637}, {'text': 'DOI 10.3389/fcvm.2022.1032755', 'font_size': 6.839285714285714}, {'text': 'Are acute type A aortic', 'font_size': 21.0}, {'text': 'dissections atherosclerotic?', 'font_size': 21.0}, {'text': 'Nimrat Grewal1,2,3*, Onur Dolmaci1,2, Evert Jansen1,', 'font_size': 10.137423404255319}, {'text': 'Robert Klautz1,2, Antoine Driessen1, Jan Lindeman4 and', 'font_size': 10.53125}, {'text': 'Robert E. Poelmann5,6', 'font_size': 10.289473684210526}, {'text': '1Department of Cardiothoracic Surgery, Amsterdam University Medical Center, Amsterdam,', 'font_size': 6.961538461538462}, {'text': 'Netherlands, 2Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden,', 'font_size': 6.964285714285714}, {'text': 'Netherlands, 3Department of Anatomy and Embryology, Leiden University Medical Center, Leiden,', 'font_size': 6.963855421686747}, {'text': 'Netherlands, 4Department of Vascular Surgery, Leiden University Medical Center, Leiden,', 'font_size': 6.961538461538462}, {'text': 'Netherlands, 5Institute of Biology, Animal Sciences and Health, Leiden University, Leiden,', 'font_size': 6.9625}, {'text': 'Netherlands, 6Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands', 'font_size': 6.964285714285714}, {'text': 'Background:  Type  A  aortic  dissections  (TAAD)  are  devastating  aortic', 'font_size': 9.0}, {'text': 'complications. Patients with Marfan syndrome, a bicuspid aortic valve or a', 'font_size': 9.0}, {'text': 'thoracic aortic aneurysm have an increased risk to develop a TAAD. These', 'font_size': 9.0}, {'text': 'predisposing conditions are characterized by a histologically thin intimal layer', 'font_size': 9.0}, {'text': 'and hardly any atherosclerosis. Little is known about the susceptibility for', 'font_size': 9.0}, {'text': 'atherosclerosis in patients with a type A aortic dissection.', 'font_size': 9.0}, {'text': 'Objective:  We  aim  to  systematically  describe  atherosclerotic  lesions  in', 'font_size': 9.0}, {'text': 'TAAD patients.', 'font_size': 9.0}, {'text': 'Materials  and  methods:  A  total  of  51  patients  with  a  TAAD  (mean  age', 'font_size': 9.0}, {'text': '62.5  ±  10.8  years,  49%  females)  and  17  control  patients  (mean  age', 'font_size': 9.0}, {'text': '63  ±  5.5  years,  53%  females)  were  included  in  this  study.  Cardiovascular', 'font_size': 9.0}, {'text': 'risk  factors  were  assessed  clinically.  All  sections  were  stained  with', 'font_size': 9.0}, {'text': 'Movat  pentachrome  and  hematoxylin  eosin.  Plaque  morphology  was', 'font_size': 9.0}, {'text': 'classiﬁed  according  to  the  modiﬁed  AHA  classiﬁcation  scheme  proposed', 'font_size': 9.0}, {'text': 'by Virmani et al.', 'font_size': 9.0}, {'text': 'Results: In the TAAD group thirty-seven percent were overweight (BMI > 25).', 'font_size': 9.0}, {'text': 'Diabetes and peripheral arterial disease were not present in any of the patients.', 'font_size': 9.0}, {'text': 'Fifty-nine percent of the patients had a history of hypertension. The intima', 'font_size': 9.0}, {'text': 'in TAAD patients was signiﬁcantly thinner as compared to the control group', 'font_size': 9.0}, {'text': '(mean thickness 143 ± 126.5 µm versus 193 ± 132 µm, p < 0.023). Seven TAAD', 'font_size': 9.0}, {'text': 'patients had a normal intima without any form of adaptive or pathological', 'font_size': 9.0}, {'text': 'thickening.  Twenty-three  TAAD  patients  demonstrated  adaptive  intimal', 'font_size': 9.0}, {'text': 'thickening. Fourteen had an intimal xanthoma, also known as fatty streaks.', 'font_size': 9.0}, {'text': 'A minority of 7 TAAD patients had progressive atherosclerotic lesions, 4 of', 'font_size': 9.0}, {'text': 'which demonstrated pathological intimal thickening, 3 patients showed early', 'font_size': 9.0}, {'text': 'ﬁbroatheroma, late ﬁbroatheroma and thin cap ﬁbroatheroma. In the control', 'font_size': 9.0}, {'text': 'group  the  majority  of  the  patients  exhibited  progressive  atherosclerotic', 'font_size': 9.0}, {'text': 'lesions: three pathologic intimal thickening, two early ﬁbroatheroma, six late', 'font_size': 9.0}, {'text': 'ﬁbroatheroma, one healed rupture and two ﬁbrotic calciﬁed plaque.', 'font_size': 9.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '01', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]
[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 2', 'font_size': 8.0}, {'text': 'Grewal et al.', 'font_size': 7.0}, {'text': '10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'Discussion: This study shows that TAAD patients hardly exhibit any form of', 'font_size': 9.0}, {'text': 'progressive atherosclerosis. The majority of TAAD patients showcase non-', 'font_size': 9.0}, {'text': 'progressive intimal lesions, whereas the control group mostly demonstrated', 'font_size': 9.0}, {'text': 'progressive intimal atherosclerotic lesions. Findings are independent of age,', 'font_size': 9.0}, {'text': 'sex, or the presence of (a history of) hypertension.', 'font_size': 9.0}, {'text': 'KEYWORDS', 'font_size': 5.5}, {'text': 'type A aortic dissection, cardiovascular risk, atherosclerosis, embryology, intima', 'font_size': 8.0}, {'text': '1. Introduction', 'font_size': 13.5}, {'text': 'A type A aortic dissection is a life-threatening condition', 'font_size': 9.0}, {'text': 'caused by a tear in the intimal layer, which allows blood to', 'font_size': 9.0}, {'text': 'surge through the middle layer of the wall, causing the vascular', 'font_size': 9.0}, {'text': 'layers to separate (dissect) from one another. Epidemiologically,', 'font_size': 9.0}, {'text': 'patients with hypertension, connective tissue disorders or a', 'font_size': 9.0}, {'text': 'bicuspid  aortic  valve  (BAV)  are  at  highest  risk  to  develop', 'font_size': 8.999999999999943}, {'text': 'a thoracic aortic aneurysm or aortic dissection (TAAD) (1,', 'font_size': 9.0}, {'text': '2).  Traditionally,  cardiovascular  risk  factors  such  as  aging,', 'font_size': 9.0}, {'text': 'dyslipidaemia, smoking, chronic kidney disease, and diabetes', 'font_size': 9.0}, {'text': 'were  related  to  the  occurrence  of  TAADs.  Thoracic  aortic', 'font_size': 9.0}, {'text': 'aneurysms and dissections can, however, develop in the absence', 'font_size': 9.0}, {'text': 'of cardiovascular risk factors and aﬀect young individuals as', 'font_size': 9.0}, {'text': 'a result of genetic disorders (3, 4). The mechanisms initiating', 'font_size': 9.0}, {'text': 'and stimulating the progression of an aortic dissection are still', 'font_size': 9.0}, {'text': 'poorly understood. More recently attention has been drawn', 'font_size': 9.0}, {'text': 'toward the intrinsic pathology of the aortic vessel wall. Bicuspid', 'font_size': 9.0}, {'text': 'aortic valve and Marfan syndrome (MFS) are both associated', 'font_size': 9.0}, {'text': 'with  an  extremely  high  risk  to  develop  a  thoracic  aortic', 'font_size': 9.0}, {'text': 'dissection (5, 6). During the last decade, a number of studies', 'font_size': 9.0}, {'text': 'dealing with the embryonic development of aortopathy in BAV', 'font_size': 9.0}, {'text': 'and MFS have signiﬁcantly improved our knowledge on the', 'font_size': 9.0}, {'text': 'etiology (7, 8). In both conditions an altered neural crest cell and', 'font_size': 9.0}, {'text': 'second heart ﬁeld contribution, separately or in combination,', 'font_size': 9.0}, {'text': 'can account for a maturation defect of the vascular smooth', 'font_size': 9.0}, {'text': 'muscle cells resulting in a structurally diﬀerent aortic root and', 'font_size': 9.0}, {'text': 'ascending aortic wall (8, 9). Besides undiﬀerentiated vascular', 'font_size': 9.0}, {'text': 'smooth muscle cells in the medial layer, signiﬁcant diﬀerences', 'font_size': 9.0}, {'text': 'in the intimal layer have also been noted in BAV and MFS.', 'font_size': 9.0}, {'text': 'The intima has been found signiﬁcantly thinner in the BAV', 'font_size': 9.0}, {'text': 'and MFS patient groups as compared to individuals with a', 'font_size': 9.0}, {'text': 'tricuspid aortic valve (TAV). Vascular smooth muscle cells and', 'font_size': 9.0}, {'text': 'smooth muscle cell-derived cells are a major source of plaque', 'font_size': 9.0}, {'text': 'cells and extracellular matrix at all stages of atherosclerosis', 'font_size': 9.0}, {'text': '(10).  Clinically,  both  BAV  and  MFS  are  characterized  by', 'font_size': 9.0}, {'text': 'signiﬁcantly  less  atherosclerosis.  Findings  which  are  in  line', 'font_size': 9.0}, {'text': 'with earlier studies highlighting that thoracic aortic aneurysms', 'font_size': 9.0}, {'text': 'are associated with decreased systemic atherosclerosis (11). We', 'font_size': 9.0}, {'text': 'postulate that the combination of a thin intimal layer and a', 'font_size': 9.0}, {'text': 'defect in vascular smooth muscle cell diﬀerentiation might act', 'font_size': 9.0}, {'text': 'protective for the development of atherosclerosis in the vessel', 'font_size': 9.0}, {'text': 'wall. Less is, however, known about the role of atherosclerosis in', 'font_size': 9.0}, {'text': 'patients with a type A aortic dissection. Recently we concluded', 'font_size': 9.0}, {'text': 'that patients with a type A aortic dissection also demonstrate', 'font_size': 9.0}, {'text': 'a signiﬁcantly thinner intimal layer, even in the absence of a', 'font_size': 9.0}, {'text': 'genetic syndrome or a bicuspid aortic valve (12). Considering', 'font_size': 9.0}, {'text': 'the overlap in pathogenetic mechanisms between BAV, MFS,', 'font_size': 9.0}, {'text': 'and type A aortic dissections it is particularly interesting to study', 'font_size': 8.999999999999941}, {'text': 'the presence of atherosclerosis in aortic dissections.', 'font_size': 9.0}, {'text': 'Earlier studies have suggested that patients with a type A', 'font_size': 9.0}, {'text': 'aortic dissection are less prone for atherosclerosis, however,', 'font_size': 9.0}, {'text': 'this has been concluded on basis of imaging studies (11, 13).', 'font_size': 9.0}, {'text': 'The novelty of this paper is that we study atherosclerosis on', 'font_size': 9.0}, {'text': 'tissue level and can detect early stages of atherosclerosis which', 'font_size': 9.0}, {'text': 'would be missed by only studying the images of transesophageal', 'font_size': 9.0}, {'text': 'echocardiography or computed tomography images (11, 14).', 'font_size': 9.0}, {'text': 'The aim of this study is to systematically classify atherosclerotic', 'font_size': 9.0}, {'text': 'lesions in the type A aortic dissection population according', 'font_size': 9.0}, {'text': 'to  the  adapted  AHA  classiﬁcation  as  proposed  by  Virmani', 'font_size': 9.0}, {'text': 'et al. (15).', 'font_size': 9.0}, {'text': '2. Materials and methods', 'font_size': 13.5}, {'text': '2.1. Patients and tissue samples', 'font_size': 12.0}, {'text': 'Fifty-one ascending aortic wall samples were obtained from', 'font_size': 9.0}, {'text': 'the  aortotomy  site  as  residual  aortic  wall  material  during', 'font_size': 9.0}, {'text': 'an  ascending  aortic  replacement  in  patients  with  an  acute', 'font_size': 9.0}, {'text': 'type  A  aortic  dissection  at  the  Leiden  University  Medical', 'font_size': 9.0}, {'text': 'Center, Leiden, Netherlands. Patients with a proven genetic', 'font_size': 9.0}, {'text': 'disorder (e.g., Marfan disease) or a bicuspid aortic valve were', 'font_size': 9.0}, {'text': 'excluded. Seventeen control aortas were obtained during post-', 'font_size': 9.0}, {'text': 'mortem autopsies.', 'font_size': 9.0}, {'text': 'Sample collection was uniform in all patients: ascending', 'font_size': 9.0}, {'text': 'aortic wall specimen were obtained from the aortotomy site. The', 'font_size': 9.0}, {'text': 'aortotomy site is classically in the middle of the ascending aorta,', 'font_size': 9.0}, {'text': 'just beneath the pericardial fold. Circular tissue was obtained', 'font_size': 9.0}, {'text': 'and embedded in paraﬃn. The complete circular ascending', 'font_size': 9.0}, {'text': 'aortic wall was sectioned to avoid sampling of the aortic tissue.', 'font_size': 9.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '02', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]
[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 3', 'font_size': 8.0}, {'text': 'Grewal et al.', 'font_size': 7.0}, {'text': '10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'Sample collection and handling was carried out according', 'font_size': 9.0}, {'text': 'to the oﬃcial guidelines of the Medical Ethical Committee of', 'font_size': 9.0}, {'text': 'Leiden University Medical Center and the code of conduct', 'font_size': 9.0}, {'text': 'of  the  Dutch  Federation  of  Biomedical  Scientiﬁc  Societies.1', 'font_size': 8.92961346153846}, {'text': 'Autopsy has been performed according to the guidelines of', 'font_size': 9.0}, {'text': 'the  pathology  department.  Tissue  collection  was  performed', 'font_size': 9.0}, {'text': 'according to the regulations and protocols for secondary tissue', 'font_size': 9.0}, {'text': 'use of the department of pathology at the Leiden University', 'font_size': 9.0}, {'text': 'Medical Center. Written informed consent was obtained.', 'font_size': 9.0}, {'text': 'After  excision,  specimens  were  ﬁxed  in  4%  formalin', 'font_size': 9.0}, {'text': '(24 h), decalciﬁed in a formic acid-formate buﬀer (120 h),', 'font_size': 9.0}, {'text': '(4  µm)', 'font_size': 9.0}, {'text': 'and  embedded  in  paraﬃn.  Transverse  sections', 'font_size': 9.0}, {'text': 'were  mounted  on  precoated  Starfrost  slides  (Klinipath  BV,', 'font_size': 9.0}, {'text': 'Duiven, Netherlands).', 'font_size': 9.0}, {'text': '2.2. Histological classiﬁcation of the', 'font_size': 12.0}, {'text': 'lesions', 'font_size': 12.0}, {'text': '(HE)', 'font_size': 9.0}, {'text': '(16).  Hematoxylin-eosin', 'font_size': 9.0}, {'text': 'The sectioning and staining protocols have been described', 'font_size': 9.0}, {'text': 'previously', 'font_size': 9.0}, {'text': 'and  Movat', 'font_size': 9.0}, {'text': 'pentachrome  staining  was  performed  for  the  histological', 'font_size': 9.0}, {'text': 'evaluation  of  all  samples  of  each  circular  aortic  specimen.', 'font_size': 9.0}, {'text': 'Sections  were  studied  with  a  Leica  BM5000  microscope', 'font_size': 9.0}, {'text': 'equipped with plan achromatic objectives (Leica Microsystems,', 'font_size': 9.0}, {'text': 'Wetzlar,  Germany).  Each  section  was  individually  classiﬁed', 'font_size': 9.0}, {'text': 'according to the modiﬁed classiﬁcation of the AHA as proposed', 'font_size': 9.0}, {'text': 'by Virmani et al. (15), by two independent observers with no', 'font_size': 9.0}, {'text': 'knowledge of the characteristics of the aortic patch (Table 1).', 'font_size': 9.0}, {'text': 'Across  the  circular  ascending  aortic  wall  tissue  the  plaque', 'font_size': 9.0}, {'text': 'with the most advanced grade of atherosclerosis according to', 'font_size': 9.0}, {'text': '1  www.FMWV.nl', 'font_size': 7.0}, {'text': 'Virmani et al. (15) called the “dominant plaque” was analyzed', 'font_size': 9.0}, {'text': 'for this study.', 'font_size': 9.0}, {'text': 'Given a role of inﬂammation in atherosclerosis we also', 'font_size': 9.0}, {'text': 'studied the presence of inﬂammatory inﬁltrates in the intimal', 'font_size': 9.0}, {'text': 'layer  of  type  A  aortic  dissection  and  control  patients.  As', 'font_size': 9.0}, {'text': 'inﬂammatory cells are acute phase proteins, an abundance of', 'font_size': 9.0}, {'text': 'these cells is encountered in the dissected medial layer. To study', 'font_size': 9.0}, {'text': 'inﬂammatory cells associated with intimal atherosclerosis, we', 'font_size': 9.0}, {'text': 'studied the inﬂux of inﬂammatory cells in the intimal layer using', 'font_size': 9.0}, {'text': 'the HE and MOVAT pentachrome stained sections, indexed', 'font_size': 9.0}, {'text': 'from zero (no inﬂammatory cells), 1 (a few cells), 2 (groups of', 'font_size': 9.0}, {'text': 'cells) to 3 (large clusters of cells).', 'font_size': 9.0}, {'text': '2.3. Statistical analysis', 'font_size': 12.0}, {'text': 'All numerical data are presented as the mean ± standard', 'font_size': 9.0}, {'text': 'deviation. Statistical diﬀerences were evaluated with the Mann–', 'font_size': 9.0}, {'text': 'Whitney U test for comparison between the groups. One, two', 'font_size': 9.0}, {'text': 'and three way ANCOVA, binary logistic regression and linear', 'font_size': 9.0}, {'text': 'regression analysis were performed to correct for age, sex and', 'font_size': 9.0}, {'text': 'hypertension. Signiﬁcance was assumed when p < 0.05 with', 'font_size': 9.0}, {'text': 'SPSS  26.0  (SPSS  Inc.,  Chicago,  IL,  USA)  was  used  for  the', 'font_size': 9.0}, {'text': 'statistical analyses.', 'font_size': 9.0}, {'text': '3. Results', 'font_size': 13.5}, {'text': '3.1. Patient population', 'font_size': 12.0}, {'text': 'A total of 51 patients with a type A aortic dissection were', 'font_size': 9.0}, {'text': 'included in the study. The mean age of the study population was', 'font_size': 9.0}, {'text': '62.5 ± 10.8 years. Females and males were evenly distributed in', 'font_size': 9.0}, {'text': 'the study group (49% females). All patients had a tricuspid aortic', 'font_size': 9.0}, {'text': 'TABLE 1  Atherosclerotic lesions in type A aortic dissection patients.', 'font_size': 7.0}, {'text': 'Morphological description', 'font_size': 9.0}, {'text': 'Associated AHA classiﬁcation', 'font_size': 9.0}, {'text': 'Normal aorta', 'font_size': 7.0}, {'text': 'Non-progressive intimal lesions', 'font_size': 8.0}, {'text': 'Adaptive intimal thickening', 'font_size': 7.0}, {'text': 'Intimal xanthoma', 'font_size': 7.0}, {'text': 'Progressive atherosclerotic lesions', 'font_size': 7.9999999999999725}, {'text': 'Pathological intimal thickening', 'font_size': 7.0}, {'text': 'Early ﬁbroatheroma', 'font_size': 7.0}, {'text': 'Late ﬁbroatheroma', 'font_size': 7.0}, {'text': 'Thin-cap ﬁbroatheroma', 'font_size': 7.0}, {'text': 'Plaque rupture', 'font_size': 7.000000000000014}, {'text': 'Healing rupture', 'font_size': 7.0}, {'text': 'Fibrotic calciﬁed plaque', 'font_size': 7.0}, {'text': '–', 'font_size': 7.0}, {'text': 'I', 'font_size': 7.0}, {'text': 'II', 'font_size': 7.0}, {'text': 'III', 'font_size': 7.0}, {'text': 'IV', 'font_size': 7.0}, {'text': 'IV/Va', 'font_size': 6.663999999999999}, {'text': '–', 'font_size': 7.0}, {'text': 'VI', 'font_size': 7.000000000000014}, {'text': 'VI', 'font_size': 7.0}, {'text': 'Vb,c, VII', 'font_size': 6.370000000000001}, {'text': 'N', 'font_size': 9.0}, {'text': '7', 'font_size': 7.0}, {'text': '24', 'font_size': 7.0}, {'text': '13', 'font_size': 7.0}, {'text': '4', 'font_size': 7.0}, {'text': '1', 'font_size': 7.0}, {'text': '1', 'font_size': 7.0}, {'text': '1', 'font_size': 7.0}, {'text': '0', 'font_size': 7.000000000000014}, {'text': '0', 'font_size': 7.0}, {'text': '0', 'font_size': 7.0}, {'text': 'Mean age', 'font_size': 9.0}, {'text': 'Female (%)', 'font_size': 9.0}, {'text': '63.3 ± 9.3', 'font_size': 7.0}, {'text': '42.9%', 'font_size': 7.0}, {'text': '62.1 ± 10', 'font_size': 7.0}, {'text': '62.6 ±', 'font_size': 7.0}, {'text': '64.2 ± 7', 'font_size': 7.0}, {'text': '51', 'font_size': 7.0}, {'text': '65', 'font_size': 7.0}, {'text': '66', 'font_size': 7.0}, {'text': '–', 'font_size': 7.000000000000014}, {'text': '–', 'font_size': 7.0}, {'text': '–', 'font_size': 7.0}, {'text': '61%', 'font_size': 7.0}, {'text': '14%', 'font_size': 7.0}, {'text': '100%', 'font_size': 7.0}, {'text': '100%', 'font_size': 7.0}, {'text': '100%', 'font_size': 7.0}, {'text': '0%', 'font_size': 7.0}, {'text': '–', 'font_size': 7.000000000000014}, {'text': '–', 'font_size': 7.0}, {'text': '–', 'font_size': 7.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '03', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]
[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 4', 'font_size': 8.0}, {'text': 'Grewal et al.', 'font_size': 7.0}, {'text': '10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'valve and no underlying aortic genetic disease was identiﬁed', 'font_size': 9.0}, {'text': 'after genetic screening by the institutional geneticist.', 'font_size': 9.0}, {'text': 'The mean body-mass index of all patients was 26.01 kg/m2;', 'font_size': 8.954997916666668}, {'text': '19 patients (37%) were considered overweight (BMI > 25).', 'font_size': 9.0}, {'text': 'Smoking status was not known for most patients. Diabetes', 'font_size': 9.0}, {'text': 'and peripheral arterial disease were not present in any of the', 'font_size': 9.0}, {'text': 'patients. Chronic obstructive pulmonary disease was seen in', 'font_size': 9.0}, {'text': 'one patient. Fifty-nine percent of the patients had a history', 'font_size': 9.0}, {'text': 'of hypertension (antihypertensive medication or systolic blood', 'font_size': 9.0}, {'text': 'pressure > 140 mmHg and diastolic > 90 mmHg in the period).', 'font_size': 9.0}, {'text': 'group  of  17  patients  were  obtained', 'font_size': 9.0}, {'text': 'the  control  patients  was', 'font_size': 9.0}, {'text': 'post-mortem.  The  mean  age  of', 'font_size': 9.0}, {'text': '63 ± 5.5 years. Females and males were evenly distributed in the', 'font_size': 9.0}, {'text': 'controls (53% females). All control patients had a non-cardiac', 'font_size': 9.0}, {'text': 'cause of death, had a tricuspid aortic valve and no underlying', 'font_size': 9.0}, {'text': 'genetic disease was known. Data on cardiovascular risk factors', 'font_size': 9.0}, {'text': 'could not be retrieved for all control patients.', 'font_size': 9.0}, {'text': 'control', 'font_size': 9.0}, {'text': 'The', 'font_size': 9.0}, {'text': '3.2. Morphometric measurements', 'font_size': 12.0}, {'text': 'The intima is deﬁned as the area between the inner surface of', 'font_size': 9.0}, {'text': 'the aortic wall, lined by the endothelial cells and the ﬁrst elastic', 'font_size': 9.0}, {'text': 'lamellae of the media (Figure 1). The mean intimal thickness in', 'font_size': 9.0}, {'text': 'all type A dissection patients was 143 ± 126.5 µm. No signiﬁcant', 'font_size': 9.0}, {'text': 'diﬀerence in intimal thickness was observed when corrected for', 'font_size': 9.0}, {'text': 'age and sex or in the presence of (a history of) hypertension', 'font_size': 9.0}, {'text': '(Age vs intimal thickness p = 0.406; sex vs intimal thickness:', 'font_size': 9.0}, {'text': 'OR 1.00 (95% CI 1.00–1.01), p = 0.669; Hypertension vs intimal', 'font_size': 9.0}, {'text': 'thickness OR 1.00 (95% CI 1.00–1.00), p = 0.860). In control', 'font_size': 9.0}, {'text': 'patients the mean intimal thickness was 193 ± 132 µm, which is', 'font_size': 9.0}, {'text': 'signiﬁcantly thicker as compared to the type A aortic dissection', 'font_size': 9.0}, {'text': 'patients (p < 0.023).', 'font_size': 9.0}, {'text': '3.3. Non-progressive intimal lesions in', 'font_size': 12.0}, {'text': 'type A aortic dissection patients', 'font_size': 12.0}, {'text': 'Atherosclerotic lesions in the intima were scored according', 'font_size': 9.0}, {'text': 'to  the  modiﬁed  classiﬁcation  of  the  AHA  as  proposed  by', 'font_size': 9.0}, {'text': 'Virmani  et  al.  (15),  Table  1.  Seven  patients  had  a  normal', 'font_size': 9.0}, {'text': 'intima without any form of adaptive or pathological thickening', 'font_size': 9.0}, {'text': '(Figure  2A).  The  intimal', 'font_size': 9.0}, {'text': 'layer  had  a  mean  thickness  of', 'font_size': 9.0}, {'text': '81 ± 62.7 µm in these patients. Mean age in this group was', 'font_size': 9.0}, {'text': '63.3 ± 9.3 years and 43% was female.', 'font_size': 9.0}, {'text': 'dissection', 'font_size': 9.0}, {'text': 'Twenty-three', 'font_size': 9.0}, {'text': 'type  A  aortic', 'font_size': 9.0}, {'text': 'patients', 'font_size': 9.0}, {'text': 'demonstrated adaptive intimal thickening (Figure 2B). In these', 'font_size': 9.0}, {'text': 'patients  the  intimal  thickening  consisted  mainly  of  smooth', 'font_size': 9.0}, {'text': 'muscle cells with an increase in proteoglycan-rich matrix. Mean', 'font_size': 9.0}, {'text': 'intimal thickness in this group was 103.4 ± 56 µm, and mean', 'font_size': 9.0}, {'text': 'age was 62.1 ± 10 years. Sixty-one percent of the patients with', 'font_size': 9.0}, {'text': 'adaptive intimal thickening were female.', 'font_size': 9.0}, {'text': 'As soon as macrophage-derived foam cells become evident', 'font_size': 9.0}, {'text': 'in the intima the lesions are referred to as intimal xanthoma,', 'font_size': 9.0}, {'text': 'also known as fatty streaks (Figure 2C). These lesions were seen', 'font_size': 9.0}, {'text': 'in 14 patients, with a mean age of 62.6 ± 14.9 years and 14% was', 'font_size': 9.0}, {'text': 'female. Mean thickness of the intima was 151.6 ± 94.4 µm.', 'font_size': 9.0}, {'text': 'FIGURE 1', 'font_size': 5.5}, {'text': 'Transverse histologic section (4 µm) of a type A aortic dissection aortic specimen. The vessel wall layers are indicated: adventitia, media, and', 'font_size': 7.000000000000014}, {'text': 'intima. The intimal layer is deﬁned as the area between the endothelial cells lining the luminal surface and the lamina elastica interna. Scale bar', 'font_size': 7.0}, {'text': 'shown in ﬁgure.', 'font_size': 7.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '04', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]
[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 5', 'font_size': 8.0}, {'text': 'Grewal et al.', 'font_size': 7.0}, {'text': '10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'FIGURE 2', 'font_size': 5.5}, {'text': 'Transverse histologic section of type A aortic dissection aortic specimen (4 µm), stained with MOVAT pentachrome. (A) Shows a normal intimal', 'font_size': 7.0}, {'text': 'layer, without any signs of adaptive or pathological thinning. In panel (B) an adaptive thickened intima is seen with mainly vascular smooth', 'font_size': 7.0}, {'text': 'muscle cells in the proteoglycan-rich matrix, a few of which are depicted with black arrows. (C) Intimal xanthoma is seen in a patient with', 'font_size': 7.0}, {'text': 'macrophage derived foam cells in the matrix, highlighted with yellow asterisks. Scale bar shown in the ﬁgures.', 'font_size': 7.0}, {'text': '3.4. Progressive atherosclerotic lesions', 'font_size': 12.0}, {'text': 'in type A aortic dissection patients', 'font_size': 12.0}, {'text': 'A total of seven patients had progressive atherosclerotic', 'font_size': 9.0}, {'text': 'lesions (Figure 3 and Table 1). The mean age of these patients', 'font_size': 9.0}, {'text': 'was 62.7 ± 7.2 years and 86% was female. Four out of these', 'font_size': 9.0}, {'text': 'seven patients demonstrated pathological intimal thickening', 'font_size': 9.0}, {'text': 'with a mean intimal thickness of 244.0 ± 156.2 µm (Figure 3A).', 'font_size': 9.0}, {'text': 'Mean  age  of  the  four  patients  was  64.2  ±  7  years,  all  of', 'font_size': 9.0}, {'text': 'which were female. The remaining three patients showed early', 'font_size': 9.0}, {'text': 'ﬁbroatheroma (Figure 3B), late ﬁbroatheroma (Figure 3C) and', 'font_size': 9.0}, {'text': 'thin cap ﬁbroatheroma (Figure 3D).', 'font_size': 9.0}, {'text': 'The severity of the atherosclerotic lesions was independent', 'font_size': 9.0}, {'text': 'of age, sex, and the cardiovascular risk factor hypertension (age', 'font_size': 9.0}, {'text': 'vs atherosclerosis classiﬁcation p = 0.976; sex vs atherosclerosis', 'font_size': 9.0}, {'text': 'classiﬁcation:  OR  0.99  (95%  CI  0.63–1.56),  p  =  0.960;', 'font_size': 9.0}, {'text': 'hypertension vs atherosclerosis classiﬁcation: OR 1.14 (95% CI', 'font_size': 9.0}, {'text': '0.72–1.78); p = 0.587).', 'font_size': 9.0}, {'text': '3.5. Atherosclerotic lesions in control', 'font_size': 12.0}, {'text': 'patients and intimal inﬂammation', 'font_size': 12.0}, {'text': 'Non-progressive atherosclerotic lesions (intimal xanthoma)', 'font_size': 9.0}, {'text': 'were  seen  in  only  three  patients  (Table  2).  Patients  from', 'font_size': 9.0}, {'text': 'exhibited  progressive', 'font_size': 9.0}, {'text': 'the', 'font_size': 9.0}, {'text': 'atherosclerotic  lesions.  Three  patients  showed  pathological', 'font_size': 9.0}, {'text': 'control  group  predominantly', 'font_size': 9.0}, {'text': 'intimal thickening (Figure 4A), two had early ﬁbroatheroma', 'font_size': 9.0}, {'text': '(Figure 4B), six demonstrated late ﬁbroatheroma (Figure 4C),', 'font_size': 9.0}, {'text': 'one had a healed rupture (Figure 4D), and two had a ﬁbrotic', 'font_size': 9.0}, {'text': 'calciﬁed plaque (Figure 4E and Table 2). Sex was randomly', 'font_size': 9.0}, {'text': 'distributed  across  the  non-  and  progressive  atherosclerotic', 'font_size': 9.0}, {'text': 'lesions.', 'font_size': 9.0}, {'text': 'in  the', 'font_size': 9.0}, {'text': 'As inﬂammatory cells are associated with the development', 'font_size': 9.0}, {'text': 'of atherosclerosis, we studied the inﬁltration of inﬂammatory', 'font_size': 9.0}, {'text': 'cells', 'font_size': 9.0}, {'text': 'layer.  The  qualitative  amount  of', 'font_size': 9.0}, {'text': 'inﬂammatory  cells  was  signiﬁcantly  higher  in  the  control', 'font_size': 9.0}, {'text': 'group as compared to the type A aortic dissection patients', 'font_size': 9.0}, {'text': '(p < 0.0001) (Figures 4F, G).', 'font_size': 9.0}, {'text': 'intimal', 'font_size': 9.0}, {'text': '4. Discussion', 'font_size': 13.5}, {'text': 'In  this', 'font_size': 9.0}, {'text': 'study  we  analyzed  atherosclerotic  lesions', 'font_size': 9.0}, {'text': 'in', 'font_size': 9.0}, {'text': 'type  A  aortic  dissection  patients.  We  found  a  very  low', 'font_size': 9.0}, {'text': 'incidence of progressive atherosclerotic lesions in the study', 'font_size': 9.0}, {'text': 'population. Major cardiovascular risk factors for atherosclerosis', 'font_size': 9.0}, {'text': '(i.e., age, sex, hypertension, and diabetes mellitus) were not', 'font_size': 9.0}, {'text': 'associated with atherosclerosis. The control group on the other', 'font_size': 9.0}, {'text': 'hand demonstrated predominantly progressive atherosclerotic', 'font_size': 9.0}, {'text': 'lesions. The intimal layer further showed signiﬁcantly more', 'font_size': 9.0}, {'text': 'inﬂux of inﬂammatory cells in the control patients as compared', 'font_size': 9.0}, {'text': 'to the intimal layer in type A aortic dissections, this ﬁnding', 'font_size': 9.0}, {'text': 'is  in  line  with  earlier  suggestions  that  inﬂammation  may', 'font_size': 9.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '05', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]
[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 6', 'font_size': 8.0}, {'text': 'Grewal et al.', 'font_size': 7.0}, {'text': '10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'FIGURE 3', 'font_size': 5.5}, {'text': 'Transverse histologic section (4 µm) of type A aortic dissection aortic specimen, stained with MOVAT pentachrome. (A) Shows pathological', 'font_size': 7.0}, {'text': 'intimal thickening, characterized by the presence of lipid pools deep within the intima near the intimal medial border with overlying vascular', 'font_size': 7.0}, {'text': 'smooth muscle cells (black arrow). Fibroatheroma is seen in panels (B–D), with an early necrotic core in panel (B), thick ﬁbrous cap in panel (C),', 'font_size': 7.0}, {'text': 'and thinning of the ﬁbrous cap in panel (D). Scale bar shown in the ﬁgures.', 'font_size': 7.0}, {'text': 'TABLE 2  Atherosclerotic lesions in control patients.', 'font_size': 7.0}, {'text': 'Morphological description', 'font_size': 9.0}, {'text': 'Associated AHA classiﬁcation', 'font_size': 9.0}, {'text': 'Normal aorta', 'font_size': 7.0}, {'text': 'Non-progressive intimal lesions', 'font_size': 8.0}, {'text': 'Adaptive intimal thickening', 'font_size': 7.0}, {'text': 'Intimal xanthoma', 'font_size': 7.0}, {'text': 'Progressive atherosclerotic lesions', 'font_size': 8.0}, {'text': 'Pathological intimal thickening', 'font_size': 7.0}, {'text': 'Early ﬁbroatheroma', 'font_size': 7.0}, {'text': 'Late ﬁbroatheroma', 'font_size': 7.0}, {'text': 'Thin-cap ﬁbroatheroma', 'font_size': 7.0}, {'text': 'Plaque rupture', 'font_size': 7.0}, {'text': 'Healing rupture', 'font_size': 7.0}, {'text': 'Fibrotic calciﬁed plaque', 'font_size': 7.0}, {'text': '–', 'font_size': 7.0}, {'text': 'I', 'font_size': 7.0}, {'text': 'II', 'font_size': 7.0}, {'text': 'III', 'font_size': 7.0}, {'text': 'IV', 'font_size': 7.0}, {'text': 'IV/Va', 'font_size': 6.663999999999999}, {'text': '–', 'font_size': 7.0}, {'text': 'VI', 'font_size': 7.0}, {'text': 'VI', 'font_size': 7.0}, {'text': 'Vb,c, VII', 'font_size': 6.369999999999997}, {'text': 'Type A dissections group', 'font_size': 9.0}, {'text': 'Control group', 'font_size': 9.0}, {'text': 'N', 'font_size': 9.0}, {'text': '7 (14%)', 'font_size': 7.0}, {'text': '24 (47%)', 'font_size': 7.0}, {'text': '13 (25%)', 'font_size': 7.0}, {'text': '4 (8%)', 'font_size': 7.0}, {'text': '1 (2%)', 'font_size': 7.0}, {'text': '1 (2%)', 'font_size': 7.0}, {'text': '1 (2%)', 'font_size': 7.0}, {'text': '0', 'font_size': 7.0}, {'text': '0', 'font_size': 7.0}, {'text': '0', 'font_size': 7.0}, {'text': 'N', 'font_size': 9.0}, {'text': '0', 'font_size': 7.0}, {'text': '0', 'font_size': 7.0}, {'text': '3 (18%)', 'font_size': 7.0}, {'text': '3 (18%)', 'font_size': 7.0}, {'text': '2 (12%)', 'font_size': 7.0}, {'text': '6 (35%)', 'font_size': 7.0}, {'text': '0', 'font_size': 7.0}, {'text': '0', 'font_size': 7.0}, {'text': '1 (6%)', 'font_size': 7.0}, {'text': '2 (12%)', 'font_size': 7.0}, {'text': 'contribute to the development of atherosclerosis. The presence', 'font_size': 9.0}, {'text': 'of inﬂammatory cells in the intimal layer of the ascending aorta', 'font_size': 9.0}, {'text': 'is an interesting ﬁnding and further studies should be performed', 'font_size': 9.0}, {'text': 'to characterize the type of inﬂammatory cells present. Findings', 'font_size': 9.0}, {'text': 'of this study are consistent with previous observations that', 'font_size': 9.0}, {'text': 'conditions predisposing for the development of a type A aortic', 'font_size': 9.0}, {'text': 'dissection, being patients with Marfan syndrome, a bicuspid', 'font_size': 9.0}, {'text': 'aortic valve and a thoracic aortic aneurysm, also associate with a', 'font_size': 9.0}, {'text': 'lower prevalence of atherosclerosis (11, 17).', 'font_size': 9.0}, {'text': 'A  type  A  aortic  dissection  is  a  life-threatening  aortic', 'font_size': 9.0}, {'text': 'complication. Although several risk factors have been described', 'font_size': 9.0}, {'text': 'predisposing  individuals  for  this  lethal  condition,  the  exact', 'font_size': 9.0}, {'text': 'pathogenesis has not yet been identiﬁed (18). Roughly, the', 'font_size': 9.0}, {'text': 'development  of  an  aortic  dissection  requires  three  main', 'font_size': 9.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '06', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]
[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 7', 'font_size': 8.0}, {'text': 'Grewal et al.', 'font_size': 7.0}, {'text': '10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'FIGURE 4', 'font_size': 5.5}, {'text': 'Transverse histologic section (4 µm) of control aortic specimen, stained with MOVAT pentachrome (A–E) and hematoxylin eosin (F) staining.', 'font_size': 7.000000000000002}, {'text': '(A) Shows pathological intimal thickening, lipid pools are seen deep within the intima near the intimal medial border with overlying vascular', 'font_size': 7.000000000000001}, {'text': 'smooth muscle cells (black arrow). (B) Shows early ﬁbroatheroma, with an early necrotic core. (C) Shows late ﬁbroatheroma with a thick ﬁbrous', 'font_size': 7.0}, {'text': 'cap overlying the necrotic core. Healed rupture is seen in panel (D) and a ﬁbrotic calciﬁed plaque in panel (E). Intimal inﬂammation is seen in', 'font_size': 7.000000000000013}, {'text': 'panel (F), the insert demonstrates a detail of the inﬂammatory cells. The qualitative amount of inﬂammatory cells was signiﬁcantly higher in the', 'font_size': 7.0}, {'text': 'control group as compared to the type A aortic dissection patients (p < 0.0001) (G). ∗∗∗∗p < 0.0001. Scale bar shown in the ﬁgures.', 'font_size': 6.937777777777778}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '07', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]
[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 8', 'font_size': 8.0}, {'text': 'Grewal et al.', 'font_size': 7.0}, {'text': '10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'stress,  a', 'font_size': 9.0}, {'text': 'pathological  conditions,  being  mechanical  wall', 'font_size': 9.0}, {'text': 'susceptible  intimal', 'font_size': 9.0}, {'text': 'layer  and  medial  degeneration  (12,  19).', 'font_size': 9.0}, {'text': 'Our previous study had shown that medial pathology in type', 'font_size': 9.0}, {'text': 'A aortic dissections is comparable with thoracic aneurysms', 'font_size': 9.0}, {'text': 'in patients with a tricuspid aortic valve with smooth muscle', 'font_size': 9.0}, {'text': 'cell nuclei loss, mucoid extracellular matrix accumulation and', 'font_size': 9.0}, {'text': 'elastic ﬁber fragmentation and loss (12). The intimal layer was,', 'font_size': 9.0}, {'text': 'however,  signiﬁcantly  thinner  as  compared  to  the  tricuspid', 'font_size': 9.0}, {'text': 'thoracic aortopathy patients, resembling the intima in patients', 'font_size': 9.0}, {'text': 'with Marfan syndrome and a bicuspid aortic valve (20, 21).', 'font_size': 9.0}, {'text': 'As  aortic  dissections  commence  with  a  tear  in  the  intimal', 'font_size': 9.0}, {'text': 'layer, it is particularly interesting to understand whether the', 'font_size': 9.0}, {'text': 'pathology  present  is  comparable  to  degenerative  or  genetic', 'font_size': 9.0}, {'text': 'thoracic aortopathy.', 'font_size': 9.0}, {'text': 'Age is an important factor in the atherosclerotic process', 'font_size': 9.0}, {'text': 'and is related with a signiﬁcant change in the physiological', 'font_size': 9.0}, {'text': 'and pathological properties of the vessel wall (22, 23). Studies', 'font_size': 9.0}, {'text': 'focusing on the natural history of atherosclerosis have shown', 'font_size': 9.0}, {'text': 'that  advanced  atherosclerotic  disease  is  common  in  people', 'font_size': 9.0}, {'text': 'over  45.  In  this  study  we  excluded  patients  with  a  genetic', 'font_size': 9.0}, {'text': 'syndrome  and/or  a  bicuspid  aortic  valve,  and  all  patients', 'font_size': 9.0}, {'text': 'analyzed were aged and presented with so-called degenerative', 'font_size': 9.0}, {'text': 'thoracic aortopathy. In the study population age did not diﬀer', 'font_size': 9.0}, {'text': 'signiﬁcantly between the sub-groups of non-and progressive', 'font_size': 9.0}, {'text': 'intimal lesions as suggested by Virmani et al. (15). Moreover,', 'font_size': 9.0}, {'text': '86%  of', 'font_size': 9.0}, {'text': 'the  patients  had  no  signs  of  progressive  intimal', 'font_size': 9.0}, {'text': 'atherosclerosis,  with  the  majority  demonstrating  a  normal', 'font_size': 9.0}, {'text': 'aorta or adaptive intimal thickening even at an advanced age.', 'font_size': 9.0}, {'text': 'This is contrast to the control group of comparable age and', 'font_size': 9.0}, {'text': 'gender distribution, which predominantly exhibited progressive', 'font_size': 9.0}, {'text': 'atherosclerotic lesions. A comparative study performed by Heng', 'font_size': 9.0}, {'text': 'et al. used heart transplant recipients as control aortic tissue', 'font_size': 9.0}, {'text': 'and found no atherosclerosis in this group (24). These patients', 'font_size': 9.0}, {'text': 'were, however, almost 5–6 years younger than the patients', 'font_size': 9.0}, {'text': 'studied in our paper. This could explain the diﬀerence in our', 'font_size': 9.0}, {'text': 'ﬁndings. Future studies should pay additional attention to the', 'font_size': 9.0}, {'text': 'cardiovascular risk factors in the control group. Our data further', 'font_size': 9.0}, {'text': 'suggests that in the type A dissection population progressive', 'font_size': 9.0}, {'text': 'aortic atherosclerosis occurs more often in women than in', 'font_size': 9.0}, {'text': 'men, an observation that concurs with clinical observations', 'font_size': 9.0}, {'text': 'showing that peripheral artery disease develops earlier and at a', 'font_size': 9.0}, {'text': 'relatively high rate in women (25, 26). In the control group a', 'font_size': 9.0}, {'text': 'female predominance was not observed in the progressive aortic', 'font_size': 9.0}, {'text': 'atherosclerotic lesions.', 'font_size': 9.0}, {'text': 'Earlier', 'font_size': 9.0}, {'text': 'studies  have  suggested  that  patients  with  a', 'font_size': 9.0}, {'text': 'thoracic  aortic  aneurysm  or  aortic  dissection  demonstrate', 'font_size': 9.0}, {'text': 'less atherosclerotic lesions (11, 13, 17, 27). These studies used', 'font_size': 9.0}, {'text': 'imaging  modalities  such  as  TEE  or  CT  scanning  to  score', 'font_size': 9.0}, {'text': 'atherosclerotic  lesions  across  the  aorta  (28).  In  this  paper', 'font_size': 9.0}, {'text': 'we  studied  the  histological  classiﬁcation  of  atherosclerosis', 'font_size': 9.0}, {'text': 'on aortic tissue level to be able to also detect early stages of', 'font_size': 9.0}, {'text': 'atherosclerosis which would be missed by only studying the', 'font_size': 9.0}, {'text': 'transesophageal  echocardiography  or  computed', 'font_size': 9.0}, {'text': 'images  of', 'font_size': 9.0}, {'text': 'tomography images (11, 14). As more than 90% of the type A', 'font_size': 9.0}, {'text': 'aortic dissections commence within the ﬁrst few centimeters of', 'font_size': 9.0}, {'text': 'the ascending aortic wall, and the aortic root and arch are not', 'font_size': 9.0}, {'text': 'always involved, we uniformly studied the ascending aorta in all', 'font_size': 9.0}, {'text': 'patients. In our earlier studies we have paid particular attention', 'font_size': 9.0}, {'text': 'to the role of shear stress on the histopathology of the aortic', 'font_size': 9.0}, {'text': 'wall in patients with a bicuspid and tricuspid aortic valve, with', 'font_size': 9.0}, {'text': 'and without dilatation and found no diﬀerence in the amount', 'font_size': 9.0}, {'text': 'of atherosclerosis (29). With magnetic resonance imaging the', 'font_size': 9.0}, {'text': 'area with maximum shear stress in the ascending aortic wall', 'font_size': 9.0}, {'text': 'was compared to the opposite site (non-jet side). Diﬀerences', 'font_size': 9.0}, {'text': 'were appreciated in the intimal thickness, but without features', 'font_size': 9.0}, {'text': 'of atherosclerosis (29).', 'font_size': 9.0}, {'text': 'We recognize that atherosclerosis is a pathological entity,', 'font_size': 9.0}, {'text': 'even though our study has dealt with many limitations by', 'font_size': 9.0}, {'text': 'performing histopathological analysis and avoiding sampling', 'font_size': 9.0}, {'text': 'errors, the lesions represent a very short segment of ascending', 'font_size': 9.0}, {'text': 'aorta,  and  areas  of  atheroma  may  be  missed.  Staining  for', 'font_size': 9.0}, {'text': 'smooth  muscle  cells  and  immune  cell  markers  should  be', 'font_size': 9.0}, {'text': 'considered  in  future  studies  to  conﬁrm  our  ﬁndings.  Our', 'font_size': 9.0}, {'text': 'study is further limited by the low number of control patients', 'font_size': 9.0}, {'text': 'versus the dissected specimen. Even though genetic screening is', 'font_size': 9.0}, {'text': 'performed in the patients to exclude an aortic genetic disease,', 'font_size': 9.0}, {'text': 'unknown genetic mutations associated with sporadic type A', 'font_size': 9.0}, {'text': 'dissections can be missed.', 'font_size': 9.0}, {'text': 'Our  ﬁndings  emphasize  that  a  type  A  aortic  dissection', 'font_size': 9.0}, {'text': 'occurs in the absence of clinical cardiovascular risk factors', 'font_size': 9.0}, {'text': 'as diabetes, dyslipidaemia and peripheral arterial and despite', 'font_size': 9.0}, {'text': 'aging most patients have minimal atherosclerotic lesions. We', 'font_size': 9.0}, {'text': 'postulate that a thin intimal layer could increase susceptibility', 'font_size': 9.0}, {'text': 'for a future aortic dissection, but at the same time acts protective', 'font_size': 9.0}, {'text': 'for systemic atherosclerosis.', 'font_size': 9.0}, {'text': 'Data availability statement', 'font_size': 13.5}, {'text': 'The raw data supporting the conclusions of this article will', 'font_size': 9.0}, {'text': 'be made available by the authors, without undue reservation.', 'font_size': 9.0}, {'text': 'Ethics statement', 'font_size': 13.5}, {'text': 'The studies involving human participants were reviewed', 'font_size': 9.0}, {'text': 'and approved by the Medical Ethical Committee of Leiden', 'font_size': 9.0}, {'text': 'University Medical Center. The patients/participants provided', 'font_size': 9.0}, {'text': 'their written informed consent to participate in this study.', 'font_size': 9.0}, {'text': 'Author contributions', 'font_size': 13.5}, {'text': 'NG conceived and designed the experiments, performed', 'font_size': 9.0}, {'text': 'the experiments, analyzed and interpreted the data, contributed', 'font_size': 9.0}, {'text': 'reagents and materials, and wrote the manuscript. OD, EJ, and', 'font_size': 9.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '08', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]
[{'text': 'fcvm-09-1032755', 'font_size': 8.0}, {'text': 'December 30, 2022', 'font_size': 8.0}, {'text': 'Time: 15:36', 'font_size': 8.0}, {'text': '# 9', 'font_size': 8.0}, {'text': 'Grewal et al.', 'font_size': 7.0}, {'text': '10.3389/fcvm.2022.1032755', 'font_size': 7.0}, {'text': 'AD  wrote  the  manuscript.  RK  conceived  and  designed  the', 'font_size': 9.0}, {'text': 'experiments, contributed reagents and materials, and wrote the', 'font_size': 9.0}, {'text': 'manuscript. JL contributed reagents and materials and wrote', 'font_size': 9.0}, {'text': 'the manuscript. RP conceived and designed the experiments,', 'font_size': 9.0}, {'text': 'analyzed and interpreted the data, contributed reagents and', 'font_size': 9.0}, {'text': 'materials, and wrote the manuscript. All authors contributed to', 'font_size': 9.0}, {'text': 'the article and approved the submitted version.', 'font_size': 9.0}, {'text': 'The reviewer M-JG declared a shared aﬃliation with the', 'font_size': 9.0}, {'text': 'authors  NG,  OD,  JL,  and  RP  to  the  handling  editor  at', 'font_size': 9.0}, {'text': 'the time of review.', 'font_size': 9.0}, {'text': 'Publisher’s note', 'font_size': 13.5}, {'text': 'Conﬂict of interest', 'font_size': 13.5}, {'text': 'The authors declare that the research was conducted in the', 'font_size': 9.0}, {'text': 'absence of any commercial or ﬁnancial relationships that could', 'font_size': 9.0}, {'text': 'be construed as a potential conﬂict of interest.', 'font_size': 9.0}, {'text': 'All claims expressed in this article are solely those of the', 'font_size': 9.0}, {'text': 'authors and do not necessarily represent those of their aﬃliated', 'font_size': 9.0}, {'text': 'organizations, or those of the publisher, the editors and the', 'font_size': 9.0}, {'text': 'reviewers. Any product that may be evaluated in this article, or', 'font_size': 9.0}, {'text': 'claim that may be made by its manufacturer, is not guaranteed', 'font_size': 9.0}, {'text': 'or endorsed by the publisher.', 'font_size': 9.0}, {'text': 'References', 'font_size': 13.5}, {'text': '1. Harris C, Croce B, Cao C. Type A aortic dissection. Ann Cardiothorac Surg.', 'font_size': 7.000000000000039}, {'text': '(2016) 5:256. doi: 10.21037/acs.2016.05.04', 'font_size': 7.0}, {'text': '2. Benedetto U, Sinha S, Dimagli A, Cooper G, Mariscalco G, Uppal R, et al.', 'font_size': 7.0}, {'text': 'Decade-long trends in surgery for acute type a aortic dissection in England: a', 'font_size': 7.0}, {'text': 'retrospective cohort study. Lancet Reg Health Eur. (2021) 7:100131. doi: 10.1016/', 'font_size': 7.0}, {'text': 'j.lanepe.2021.100131', 'font_size': 7.0}, {'text': '3. Bossone E, Masiello P, Panza A, Alfano A, Tedesco L, Priante O, et al. Acute', 'font_size': 7.0}, {'text': 'aortic dissection in the young: clinical series. Minerva Chir. (2007) 62:305–7.', 'font_size': 7.0}, {'text': '4. Vapnik JS, Kim JB, Isselbacher EM, Ghoshhajra BB, Cheng Y, Sundt TM III,', 'font_size': 7.0}, {'text': 'et al. Characteristics and outcomes of ascending versus descending thoracic aortic', 'font_size': 7.0}, {'text': 'aneurysms. Am J Card. (2016) 117:1683–90. doi: 10.1016/j.amjcard.2016.02.048', 'font_size': 7.0}, {'text': '5. Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM,', 'font_size': 7.0}, {'text': 'et al. Incidence of aortic complications in patients with bicuspid aortic valves.', 'font_size': 7.0}, {'text': 'JAMA. (2011) 306:1104–12. doi: 10.1001/jama.2011.1286', 'font_size': 7.0}, {'text': '6. Roman MJ, Devereux RB. Aortic dissection risk in Marfan syndrome. J Am', 'font_size': 7.0}, {'text': 'Coll Cardiol. (2020) 75:854–6. doi: 10.1016/j.jacc.2019.12.042', 'font_size': 7.0}, {'text': '7. Grewal N, Groot AC, Lindeman JH, Klautz A, Driessen A, Klautz RJM, et al.', 'font_size': 7.0}, {'text': 'Normal and abnormal development of the aortic valve and ascending aortic wall:', 'font_size': 7.0}, {'text': 'a comprehensive overview of the embryology and pathology of the bicuspid aortic', 'font_size': 7.0}, {'text': 'valve. Ann Cardiothorac Surg. (2022) 11:380–8. doi: 10.21037/acs-2021-bav-14', 'font_size': 7.0}, {'text': '8. Granata A, Serrano F, Bernard WG, McNamara M, Low L, Sastry P, et al.', 'font_size': 7.0}, {'text': 'An iPSC-derived vascular model of Marfan syndrome identiﬁes key mediators of', 'font_size': 7.0}, {'text': 'smooth muscle cell death. Nat Genet. (2017) 49:97–109. doi: 10.1038/ng.3723', 'font_size': 7.0}, {'text': '9. Harmon AW, Nakano A. Nkx2-5 lineage tracing visualizes the distribution of', 'font_size': 7.0}, {'text': 'second heart ﬁeld-derived aortic smooth muscle. Genesis. (2000) 2013:862–9.', 'font_size': 7.0}, {'text': '10. Basatemur GL, Jørgensen HF, Clarke MCH, Bennett MR, Mallat Z. Vascular', 'font_size': 7.0}, {'text': 'smooth muscle cells in atherosclerosis. Nat Rev Cardiol. (2019) 16:727–44.', 'font_size': 7.0}, {'text': '11. Achneck H, Modi B, Shaw C, Rizzo J, Albornoz G, Fusco D, et al. Ascending', 'font_size': 7.0}, {'text': 'thoracic aneurysms are associated with decreased systemic atherosclerosis. Chest.', 'font_size': 7.0}, {'text': '(2005) 128:1580–6. doi: 10.1378/chest.128.3.1580', 'font_size': 7.0}, {'text': '12. Grewal N, Velders BJJ, Gittenberger-de Groot AC, Poelmann R, Klautz RJM,', 'font_size': 7.0}, {'text': 'Van Brakel TJ, et al. A systematic histopathologic evaluation of type-A aortic', 'font_size': 7.0}, {'text': 'dissections implies a uniform multiple-hit causation. J Cardiovasc Dev Dis. (2021)', 'font_size': 7.0}, {'text': '8:12. doi: 10.3390/jcdd8020012', 'font_size': 7.0}, {'text': '13. Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Sicks JD, Fought AJ,', 'font_size': 7.0}, {'text': 'et al. Is aortic dilatation an atherosclerosis-related process? clinical, laboratory, and', 'font_size': 7.0}, {'text': 'transesophageal echocardiographic correlates of thoracic aortic dimensions in the', 'font_size': 7.0}, {'text': 'population with implications for thoracic aortic aneurysm formation. J Am Coll', 'font_size': 7.0}, {'text': 'Cardiol. (2003) 42:1076–83.', 'font_size': 7.0}, {'text': '14. Weissler-Snir  A,  Greenberg  G,  Shapira  Y,  Weisenberg  D,  Monakier  D,', 'font_size': 7.0}, {'text': 'Nevzorov R, et al. Transoesophageal echocardiography of aortic atherosclerosis:', 'font_size': 7.0}, {'text': 'the additive value of three-dimensional over two-dimensional imaging. Eur Heart', 'font_size': 7.000000000000014}, {'text': 'J Cardiovasc Imaging. (2014) 16:389–94. doi: 10.1093/ehjci/jeu195', 'font_size': 7.0}, {'text': '15. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from', 'font_size': 7.0}, {'text': 'sudden coronary death: a comprehensive morphological classiﬁcation scheme for', 'font_size': 7.0}, {'text': 'atherosclerotic lesions. Arterioscler Thromb Vasc Biol. (2000) 20:1262–75.', 'font_size': 7.0}, {'text': '16. Grewal N, Gittenberger-de Groot AC, Thusen JV, Wisse LJ, Bartelings MM,', 'font_size': 7.0}, {'text': 'DeRuiter MC, et al. The development of the ascending aortic wall in tricuspid and', 'font_size': 7.0}, {'text': 'bicuspid aortic valve: a process from maturation to degeneration. J Clin Med. (2020)', 'font_size': 7.0}, {'text': '9:908. doi: 10.3390/jcm9040908', 'font_size': 7.0}, {'text': '17. Dolmaci OBLJ, Lindeman JHN, Driessen AHG, Klautz RJM, van Brakel', 'font_size': 7.0}, {'text': 'TJ, Hans-Marc J. The extent of coronary artery disease in patients with stenotic', 'font_size': 7.0}, {'text': 'bicuspid versus tricuspid aortic valves. J Am Heart Assoc. (2021) 10:e020080.', 'font_size': 7.0}, {'text': '18. Howard DP, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM.', 'font_size': 7.0}, {'text': 'Population-based study of incidence and outcome of acute aortic dissection and', 'font_size': 7.0}, {'text': 'premorbid risk factor control: 10-year results from the Oxford vascular study.', 'font_size': 7.0}, {'text': 'Circulation. (2013) 127:2031–7. doi: 10.1161/CIRCULATIONAHA.112.000483', 'font_size': 7.0}, {'text': '19. Akutsu K. Etiology of aortic dissection. Gen Thorac Cardiovasc Surg. (2019)', 'font_size': 7.0}, {'text': '67:271–6. doi: 10.1007/s11748-019-01066-x', 'font_size': 7.0}, {'text': '20. Grewal N, Goumans MJ, deRuiter M, Klautz RJ, Poelmann R, Mulder B, et al.', 'font_size': 7.0}, {'text': 'Aortopathy in bicuspid aortic valve and Marfan syndrome is characterized by a', 'font_size': 7.0}, {'text': 'lack of activation potential of the epicardium in the ascending aorta. Int J Pathol', 'font_size': 7.0}, {'text': 'Clin Res. (2017) 3:51. doi: 10.23937/2469-5807/1510051', 'font_size': 7.0}, {'text': '21. Grewal  N,  Gittenberger-de  Groot  AC.  Pathogenesis  of  aortic  wall', 'font_size': 7.0}, {'text': 'complications in Marfan syndrome. Cardiovasc Pathol. (2018) 33:62–9.', 'font_size': 7.0}, {'text': '22. van Dijk RA, Virmani R, von der Thusen JH, Schaapherder AF, Lindeman', 'font_size': 7.0}, {'text': 'JH. The natural history of aortic atherosclerosis: a systematic histopathological', 'font_size': 7.0}, {'text': 'evaluation of the peri-renal region. Atherosclerosis. (2010) 210:100–6. doi: 10.1016/', 'font_size': 7.0}, {'text': 'j.atherosclerosis.2009.11.016', 'font_size': 7.0}, {'text': '23. O’Rourke  MF.  Arterial  aging:  pathophysiological  principles.  Vasc  Med.', 'font_size': 7.0}, {'text': '(2007) 12:329–41. doi: 10.1177/1358863X07083392', 'font_size': 7.0}, {'text': '24. Heng E, Stone JR, Kim JB, Lee H, MacGillivray TE, Sundt TM. Comparative', 'font_size': 7.0}, {'text': 'histology of aortic dilatation associated with bileaﬂet versus trileaﬂet aortic valves.', 'font_size': 7.0}, {'text': 'Ann Thorac Surg. (2015) 100:2095–101. doi: 10.1016/j.athoracsur.2015.05.105', 'font_size': 7.0}, {'text': '25. Leng GC, Papacosta O, Whincup P, Wannamethee G, Walker M, Ebrahim S,', 'font_size': 6.999999999999972}, {'text': 'et al. Femoral atherosclerosis in an older British population: prevalence and risk', 'font_size': 7.0}, {'text': 'factors. Atherosclerosis. (2000) 152:167–74. doi: 10.1016/S0021-9150(99)00447-5', 'font_size': 7.0}, {'text': '26. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, et al. High', 'font_size': 7.0}, {'text': 'prevalence of peripheral arterial disease and co-morbidity in 6880 primary care', 'font_size': 7.0}, {'text': 'patients: cross-sectional study. Atherosclerosis. (2004) 172:95–105. doi: 10.1016/', 'font_size': 7.0}, {'text': 'S0021-9150(03)00204-1', 'font_size': 7.0}, {'text': '27. Dolmaci OB, Driessen AHG, Klautz RJM, Poelmann R, Lindeman JHN,', 'font_size': 7.0}, {'text': 'Grewal N. Comparative evaluation of coronary disease burden: bicuspid valve', 'font_size': 7.0}, {'text': 'disease  is  not  atheroprotective.  Open  Heart.  (2021)  8:e001772.  doi:  10.1136/', 'font_size': 7.0}, {'text': 'openhrt-2021-001772', 'font_size': 7.0}, {'text': '28. Khoury Z, Gottlieb S, Stern S, Keren A. Frequency and distribution of', 'font_size': 7.0}, {'text': 'atherosclerotic plaques in the thoracic aorta as determined by transesophageal', 'font_size': 7.0}, {'text': 'echocardiography in patients with coronary artery disease. Am J Card. (1997)', 'font_size': 7.0}, {'text': '79:23–7. doi: 10.1016/S0002-9149(96)00670-4', 'font_size': 7.000000000000014}, {'text': '29. Grewal N, Girdauskas E, deRuiter M, Goumans MJ, Lindeman JH, Disha K,', 'font_size': 7.0}, {'text': 'et al. The eﬀects of hemodynamics on the inner layers of the aortic wall in patients', 'font_size': 7.0}, {'text': 'with a bicuspid aortic valve. Int Mol Med. (2017) 4:5. doi: 10.15761/IMM.100', 'font_size': 7.0}, {'text': '0308', 'font_size': 7.0}, {'text': 'Frontiers in Cardiovascular Medicine', 'font_size': 7.0}, {'text': '09', 'font_size': 7.0}, {'text': 'frontiersin.org', 'font_size': 7.0}]




[{'text': 'Quality Improvement Study', 'font_size': 9.962599999999952}, {'text': 'Medicine®', 'font_size': 36.51048888888887}, {'text': 'OPEN', 'font_size': 9.0}, {'text': 'Ensuring trust in COVID-19 data', 'font_size': 19.925299999999993}, {'text': 'A retrospective cohort study', 'font_size': 15.94029999999998}, {'text': 'Daniel Antwi-Amoabeng, MD, MSca, Bryce D. Beutler, MDa,∗', 'font_size': 10.17598163265314}, {'text': 'Sumaiya Mahboob, MDa, Nageshwara Gullapalli, MD, MPHa, Rudy Tedja, DOa,b,c,', 'font_size': 10.090781818181895}, {'text': 'Farah Madhani-Lovely, MDa,b, Chris Rowan, MDa,d', 'font_size': 9.96244285714293}, {'text': ', Gurpreet Chahal, MDa,', 'font_size': 10.286310000000082}, {'text': 'Abstract', 'font_size': 7.970199999999977}, {'text': 'There are no standardized methods for collecting and reporting coronavirus disease-2019 (COVID-19) data. We aimed to compare', 'font_size': 8.966300000000047}, {'text': 'the proportion of patients admitted for COVID-19-related symptoms and those admitted for other reasons who incidentally tested', 'font_size': 8.966300000000047}, {'text': 'positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).', 'font_size': 8.966300000000047}, {'text': 'Retrospective cohort study', 'font_size': 8.966300000000047}, {'text': 'Data  were  sampled  twice  weekly  between  March  26  and  June  6,  2020  from  a  “COVID-19  dashboard,”  a  system-wide', 'font_size': 8.966300000000047}, {'text': 'administrative database that includes the number of hospitalized patients with a positive SARS-CoV-2 polymerase chain reaction', 'font_size': 8.966300000000047}, {'text': 'test. Patient charts were subsequently reviewed and the principal reason for hospitalization abstracted.', 'font_size': 8.966300000000047}, {'text': 'Data collected during a statewide lockdown revealed that 92 hospitalized patients had positive SARS-CoV-2 test results. Among', 'font_size': 8.96629999999999}, {'text': 'these individuals, 4.3% were hospitalized for reasons other than COVID-19-related symptoms but were incidentally found to be', 'font_size': 8.96629999999999}, {'text': 'SARS-CoV-2-positive. After the lockdown was suspended, the total inpatient census of SARS-CoV-2-positive patients increased to', 'font_size': 8.96629999999999}, {'text': '128, 20.3% of whom were hospitalized for non-COVID-19-related complaints.', 'font_size': 8.96629999999999}, {'text': 'In the absence of a statewide lockdown, there was a signiﬁcant increase in the proportion of patients admitted for non-COVID-19-', 'font_size': 8.96629999999999}, {'text': 'related complaints who were incidentally found to be SARS-CoV-2-positive. In order to ensure data integrity, coding should', 'font_size': 8.96629999999999}, {'text': 'distinguish between patients with COVID-19-related symptoms and asymptomatic patients carrying the SARS-CoV-2 virus.', 'font_size': 8.96629999999999}, {'text': 'Abbreviations: COVID-19 = coronavirus disease-2019, ICD-10 = International Classiﬁcation of Diseases, Tenth Edition, SARS-', 'font_size': 8.838360550458702}, {'text': 'CoV-2 = severe acute respiratory syndrome coronavirus 2.', 'font_size': 8.96629999999999}, {'text': 'Keywords: coronavirus, coronavirus disease, coronavirus disease-2019, epidemiology, health systems, severe acute respiratory', 'font_size': 8.8869646017699}, {'text': 'syndrome coronavirus 2', 'font_size': 8.96629999999999}, {'text': '1.  Introduction', 'font_size': 9.464599999999962}, {'text': 'Global  prediction  models  indicate  that  a  fourth  wave  of', 'font_size': 8.96629999999999}, {'text': 'coronavirus disease-2019 (COVID-19), driven by the emerging', 'font_size': 8.96629999999999}, {'text': 'delta variant, may be approaching. Accurate epidemiologic data', 'font_size': 8.96629999999999}, {'text': 'is  therefore  of  paramount  importance  in  modeling  resource', 'font_size': 8.96629999999999}, {'text': 'Editor: Maya Saranathan.', 'font_size': 6.973799999999983}, {'text': 'The authors have no funding and conﬂicts of interest to disclose.', 'font_size': 6.973799999999983}, {'text': 'This study was exempt from approval by the Institutional Review Board, as it', 'font_size': 6.973800000000011}, {'text': 'was conducted as a quality improvement project.', 'font_size': 6.97380000000001}, {'text': 'The datasets generated during and/or analyzed during the current study are', 'font_size': 6.973800000000011}, {'text': 'available from the corresponding author on reasonable request.', 'font_size': 6.973800000000012}, {'text': 'a Department of Internal Medicine, University of Nevada Reno School of', 'font_size': 6.935045000000012}, {'text': 'Medicine, Reno, NV,  b Department of Pulmonary and Critical Care Medicine,', 'font_size': 6.936890476190488}, {'text': 'Renown Health, Reno, NV,  c Department of Infection Prevention, Renown Health,', 'font_size': 6.939094029850757}, {'text': 'Reno, NV,  d Institute for Heart and Vascular Health, Renown Regional Medical', 'font_size': 6.938026153846165}, {'text': 'Center, Reno, NV.', 'font_size': 6.973800000000011}, {'text': '∗', 'font_size': 4.648500000000013}, {'text': 'Correspondence: Bryce D. Beutler, 1155 Mill Street, W-11, Reno, NV 89052', 'font_size': 6.973800000000011}, {'text': '(e-mail: brycebeutler@hotmail.com).', 'font_size': 6.973800000000011}, {'text': 'Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.', 'font_size': 6.973800000000011}, {'text': 'This is an open access article distributed under the Creative Commons', 'font_size': 6.973800000000012}, {'text': 'Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and', 'font_size': 6.973799999999997}, {'text': 'reproduction in any medium, provided the original work is properly cited.', 'font_size': 6.973799999999997}, {'text': 'How to cite this article: Antwi-Amoabeng D, Beutler BD, Chahal G, Mahboob S,', 'font_size': 6.973799999999997}, {'text': 'Gullapalli N, Tedja R, Madhani-Lovely F, Rowan C. Ensuring trust in COVID-19', 'font_size': 6.973799999999997}, {'text': 'data: a retrospective cohort study. Medicine 2021;100:35(e26972).', 'font_size': 6.973799999999997}, {'text': 'Received: 29 October 2020 / Received in ﬁnal form: 6 July 2021 / Accepted: 1', 'font_size': 6.973799999999998}, {'text': 'August 2021', 'font_size': 6.973800000000004}, {'text': 'http://dx.doi.org/10.1097/MD.0000000000026972', 'font_size': 6.973800000000004}, {'text': 'utilization and health care systems planning. At present, there are', 'font_size': 8.96629999999999}, {'text': 'no standardized methods for collecting and reporting COVID-19', 'font_size': 8.96629999999999}, {'text': 'data.  In  light  of  growing  distrust  in  central  governments  to', 'font_size': 8.96629999999999}, {'text': 'effectively manage this global crisis, data integrity has become all', 'font_size': 8.966299999999988}, {'text': 'the  more  important  to  increase  conﬁdence  in  public  health', 'font_size': 8.96629999999999}, {'text': 'interventions.[1] Indeed, even clinicians and public health experts', 'font_size': 8.81682499999999}, {'text': 'have begun to question the quality of COVID-19 data that have', 'font_size': 8.96629999999999}, {'text': 'been  published  in  the  medical', 'font_size': 8.96629999999999}, {'text': 'study', 'font_size': 8.96629999999999}, {'text': 'recent', 'font_size': 8.96629999999999}, {'text': 'retractions have done little to alleviate these concerns.[3]', 'font_size': 8.797083018867943}, {'text': 'literature[2];', 'font_size': 8.325692857142855}, {'text': 'A central challenge of COVID-19 analytics is related to the', 'font_size': 8.966300000000018}, {'text': 'high  proportion  of  asymptomatic  infections;  morbidity  and', 'font_size': 8.966300000000018}, {'text': 'mortality data is inextricably linked to the number of incidental', 'font_size': 8.966300000000018}, {'text': 'positive severe acute respiratory syndrome coronavirus 2 (SARS-', 'font_size': 8.966300000000018}, {'text': 'CoV-2)', 'font_size': 8.966300000000018}, {'text': 'tests  among  patients  hospitalized  for  conditions', 'font_size': 8.966300000000018}, {'text': 'unrelated to COVID-19. We aimed to investigate the distribution', 'font_size': 8.966300000000018}, {'text': 'of patients who were admitted for COVID-19 symptoms versus', 'font_size': 8.966300000000018}, {'text': 'those  admitted  for  unrelated  reasons  who  were  incidentally', 'font_size': 8.966300000000018}, {'text': 'found  to  have  COVID-19.  In  addition,  we  compared  data', 'font_size': 8.966300000000018}, {'text': 'obtained during a statewide lockdown with that obtained in the', 'font_size': 8.966300000000018}, {'text': 'postlockdown  period  to  determine  the  effect  of  community', 'font_size': 8.966300000000018}, {'text': 'spread on the rate of incidental positive tests.', 'font_size': 8.966300000000004}, {'text': '2. Methods', 'font_size': 9.464600000000004}, {'text': 'Between March 26 and June 6, 2020, we sampled data from our', 'font_size': 8.966300000000004}, {'text': '“COVID-19 Dashboard,” a system-wide administrative data-', 'font_size': 8.966300000000004}, {'text': 'base that includes the number of hospitalized patients with a', 'font_size': 8.966300000000004}, {'text': 'positive SARS-CoV-2 polymerase chain reaction test. We deﬁned', 'font_size': 8.966300000000004}, {'text': '1', 'font_size': 7.970199999999998}]
[{'text': 'Antwi-Amoabeng et al. Medicine (2021) 100:35', 'font_size': 7.970199999999977}, {'text': 'Medicine', 'font_size': 7.970199999999977}, {'text': '“incidental  positive  cases”  as  patients  hospitalized  for  non-', 'font_size': 8.966299999999936}, {'text': 'COVID-related conditions who tested positive for SARS-CoV-2', 'font_size': 8.966299999999933}, {'text': 'but were represented as hospitalized COVID-19 patients in the', 'font_size': 8.966299999999933}, {'text': 'database. Using the Mann–Whitney U test, we compared the', 'font_size': 8.966299999999938}, {'text': 'mean daily frequency of incidental positive cases during and after', 'font_size': 8.966299999999933}, {'text': 'a statewide lockdown, which was imposed between March 26', 'font_size': 8.966299999999933}, {'text': 'and April 30 and during which time all nonessential businesses', 'font_size': 8.966299999999933}, {'text': 'were required to close and nonemergent surgical procedures were', 'font_size': 8.966299999999933}, {'text': 'postponed. The difference in the proportion of incidental positive', 'font_size': 8.966299999999933}, {'text': 'cases during and after the lockdown was assessed using a 2-', 'font_size': 8.966299999999933}, {'text': 'sample Chi square test of proportions at 95% conﬁdence. Stata', 'font_size': 8.966299999999935}, {'text': 'version 16 (StataCorp., College Station, TX) was used for the', 'font_size': 8.966299999999933}, {'text': 'statistical analysis.', 'font_size': 8.966299999999933}, {'text': 'The  study  was  exempt  from  approval  by  the  Institutional', 'font_size': 8.966299999999933}, {'text': 'Review Board, as it was conducted as a quality improvement', 'font_size': 8.966299999999933}, {'text': 'project.', 'font_size': 8.966299999999933}, {'text': '3.  Results', 'font_size': 9.464600000000019}, {'text': 'Data collected between March 26 and April 30 (33 days of', 'font_size': 8.966299999999933}, {'text': 'lockdown) revealed that 92 hospitalized patients had positive', 'font_size': 8.966299999999933}, {'text': 'SARS-CoV-2 test results. Among these individuals, 4.3% were', 'font_size': 8.966299999999933}, {'text': 'hospitalized  for  reasons  other  than  COVID-19  but  were', 'font_size': 8.966299999999933}, {'text': 'incidentally found to be SARS-CoV-2-positive. Between May 1', 'font_size': 8.966299999999933}, {'text': 'and June 6 (33 days of re-opening), the total inpatient census of', 'font_size': 8.966299999999933}, {'text': 'SARS-CoV-2-positive patients increased to 128, 20.3% of whom', 'font_size': 8.966299999999933}, {'text': 'were hospitalized for non-COVID-19-related complaints.', 'font_size': 8.966299999999933}, {'text': 'The  daily  trend  in  SARS-CoV-2-positive  patients  remained', 'font_size': 8.966299999999933}, {'text': 'stable in the lockdown period but increased approximately 2 weeks', 'font_size': 8.966299999999933}, {'text': 'after the re-opening (Fig. 1). The mean number of daily non-', 'font_size': 8.966299999999933}, {'text': 'COVID-19-related admissions was signiﬁcantly higher after the re-', 'font_size': 8.966299999999935}, {'text': 'opening period as compared to the lockdown period (2.6 versus 1,', 'font_size': 8.966299999999933}, {'text': 'respectively; Fig. 2). In addition, there was a statistically signiﬁcant', 'font_size': 8.966299999999935}, {'text': '(P = .001) increase in the proportion of incidental positive SARS-', 'font_size': 8.966299999999936}, {'text': 'CoV-2 tests between the lockdown and immediate postlockdown', 'font_size': 8.966299999999933}, {'text': 'periods (4.3% and 20.3%, respectively). The relationship between', 'font_size': 8.966299999999933}, {'text': 'timeline and hospitalization type is further illustrated in Table 1.', 'font_size': 8.966299999999933}, {'text': 'This study included 220 hospitalizations between March 26 and', 'font_size': 8.966300000000047}, {'text': 'June 6, 2020. All patients were coded as being hospitalized for', 'font_size': 8.96629999999999}, {'text': 'COVID-19. The total rate of incidental SARS-CoV-2 positivity in', 'font_size': 8.96629999999999}, {'text': 'the cohort was 13.6%.', 'font_size': 8.96629999999999}, {'text': '4.  Discussion', 'font_size': 9.464599999999962}, {'text': 'In June 2020, the National Institutes of Health announced the', 'font_size': 8.96629999999999}, {'text': 'creation of the National COVID Cohort Collaborative, which', 'font_size': 8.96629999999999}, {'text': 'Figure 1. Trends in the daily number of hospitalizations of SARS-CoV-2 positive patients due to COVID symptoms versus not due to COVID symptoms. Vertical line', 'font_size': 7.471800000000002}, {'text': '(arrow) denotes the transition from the lockdown period (March 24th to April 30th) and the re-opening period (May 1st to June 6th). COVID = coronavirus disease,', 'font_size': 7.324167407407408}, {'text': 'SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.', 'font_size': 7.471800000000002}, {'text': '2', 'font_size': 7.970199999999998}]
[{'text': 'Antwi-Amoabeng et al. Medicine (2021) 100:35', 'font_size': 7.970199999999977}, {'text': 'www.md-journal.com', 'font_size': 7.970199999999977}, {'text': 'due to patient concerns for COVID-19 exposure.[5] During the', 'font_size': 8.793828846153778}, {'text': 'lockdown and immediate postlockdown periods, our hospital', 'font_size': 8.966299999999933}, {'text': 'instituted a policy of SARS-CoV-2 screening for all patients who', 'font_size': 8.966299999999933}, {'text': 'were to be hospitalized. A consequence of this policy was an', 'font_size': 8.966299999999933}, {'text': 'increase  in  the  number  of  positive  cases  among  hospitalized', 'font_size': 8.966299999999933}, {'text': 'patients. Examples include a teenager with a traumatic femur', 'font_size': 8.966299999999933}, {'text': 'fracture, a primigravid patient in labor, and a middle-aged man', 'font_size': 8.966299999999933}, {'text': 'with appendicitis, all of whom were incidentally found to be', 'font_size': 8.966299999999933}, {'text': 'SARS-CoV-2-positive  but  were  erroneously  represented  as', 'font_size': 8.966299999999933}, {'text': 'hospitalized COVID-19 patients in the hospital administrative', 'font_size': 8.966299999999933}, {'text': 'database.', 'font_size': 8.966299999999933}, {'text': 'Two new provisional International Classiﬁcation of Diseases,', 'font_size': 8.966299999999935}, {'text': 'Tenth  Edition  (ICD-10)  codes  are  used  for  establishing  a', 'font_size': 8.966299999999933}, {'text': 'diagnosis of COVID-19: U07.1, which denotes positive identiﬁ-', 'font_size': 8.966299999999935}, {'text': 'cation of the SARS-CoV-2 virus and U07.2, which indicates no', 'font_size': 8.966299999999933}, {'text': 'laboratory conﬁrmation of the virus in the setting of a clinical', 'font_size': 8.966299999999935}, {'text': 'diagnosis of COVID-19. These codes are utilized for both clinical', 'font_size': 8.966299999999933}, {'text': 'and epidemiological coding of the disease and will be used to', 'font_size': 8.966299999999933}, {'text': 'monitor incidence, prevalence, hospitalizations, and in-hospital', 'font_size': 8.966299999999933}, {'text': 'outcomes.[6] Since up to 30% of patients who test positive for', 'font_size': 8.793828846153884}, {'text': 'SARS-CoV-2 may be asymptomatic, hospital data standardiza-', 'font_size': 8.96629999999999}, {'text': 'tion is vital to clearly distinguish incidental from symptomatic', 'font_size': 8.96629999999999}, {'text': 'cases. Indeed, there is a need to deﬁne these codes to indicate', 'font_size': 8.96629999999999}, {'text': 'which patients suffered signiﬁcant clinical effects of COVID-19,', 'font_size': 8.96629999999999}, {'text': 'as the current recommendation is to use additional diagnoses to', 'font_size': 8.96629999999999}, {'text': 'identify disease manifestations.[7] It will also be prudent to deﬁne', 'font_size': 8.81429152542372}, {'text': 'ICD-10  codes  for  organ-speciﬁc  COVID-19  dysfunction  in', 'font_size': 8.96629999999999}, {'text': 'affected patients.', 'font_size': 8.96629999999999}, {'text': 'Notably, data suggest that a signiﬁcant proportion of COVID-', 'font_size': 8.96629999999999}, {'text': '19 cases go unreported[8,9]; this affects calculation of the R0 as', 'font_size': 8.645996428571422}, {'text': 'well as the case fatality rate. Estimates of the true disease burden', 'font_size': 8.96629999999999}, {'text': 'rely on correlation of symptomatic, asymptomatic, and unre-', 'font_size': 8.96629999999999}, {'text': 'ported cases, and thus it is essential to deﬁne ICD-10 codes', 'font_size': 8.96629999999999}, {'text': 'appropriately to distinguish between incidental and noninciden-', 'font_size': 8.96629999999999}, {'text': 'tal cases.', 'font_size': 8.96629999999999}, {'text': 'This report draws attention to inherent ﬂaws in the current', 'font_size': 8.96629999999999}, {'text': 'practice of collecting administrative data on COVID-19 hospital-', 'font_size': 8.96629999999999}, {'text': 'izations. We believe the practices described herein are represen-', 'font_size': 8.96629999999999}, {'text': 'tative of the general United States hospital setting. However, we', 'font_size': 8.96629999999999}, {'text': 'are limited by our inability to include data from other hospitals in', 'font_size': 8.96629999999999}, {'text': 'our analysis. Further, our sample size is rather small and may', 'font_size': 8.96629999999999}, {'text': 'underestimate  the  proportion  of  hospitalizations  with  SARS-', 'font_size': 8.96629999999999}, {'text': 'CoV-2 infection without clinical evidence of COVID-19 disease.', 'font_size': 8.96629999999999}, {'text': '5. Conclusion', 'font_size': 9.464600000000019}, {'text': 'Scientiﬁc evidence represents the foundation of all effective public', 'font_size': 8.966300000000018}, {'text': 'health policy. Implementation of population-level interventions', 'font_size': 8.96630000000002}, {'text': 'often require years of epidemiologic data collection. The COVID-', 'font_size': 8.966300000000018}, {'text': '19 pandemic is rapidly evolving as new variants emerge, and the', 'font_size': 8.966300000000018}, {'text': 'medical community is frantically trying to stem the spread of the', 'font_size': 8.966300000000018}, {'text': 'disease while collecting data to inform public health interven-', 'font_size': 8.966300000000018}, {'text': 'tions.  However,  ensuring  data  integrity  is  crucial.  We  must', 'font_size': 8.966300000000018}, {'text': 'establish  clear  deﬁnitions  of  disease  states  and  associated', 'font_size': 8.966300000000018}, {'text': 'outcomes  in  order  to  safeguard  clinical  and  epidemiological', 'font_size': 8.966300000000004}, {'text': 'research;  we  believe  that', 'font_size': 8.966300000000004}, {'text': 'this  will  ultimately  strengthen', 'font_size': 8.966300000000004}, {'text': 'interventions to control the disease. We need to change reporting', 'font_size': 8.966300000000004}, {'text': 'to designate which patients are admitted for COVID-19 and', 'font_size': 8.966300000000004}, {'text': 'which are admitted with COVID-19. Furthermore, designating', 'font_size': 8.966300000000004}, {'text': 'the extent of organ involvement will be valuable in monitoring', 'font_size': 8.966300000000004}, {'text': 'long-term sequalae of COVID-19. Public trust must be regained', 'font_size': 8.966299999999997}, {'text': 'in our collective efforts to manage this pandemic.', 'font_size': 8.966300000000004}, {'text': '3', 'font_size': 7.970199999999998}, {'text': 'Figure 2.  Comparison of the mean number of daily hospitalizations (error bars', 'font_size': 7.471800000000016}, {'text': '= conﬁdence intervals) of patients who did not have COVID-19 symptoms', 'font_size': 7.47180000000003}, {'text': 'during the lockdown period (March 24th to April 30th) and the re-opening (May', 'font_size': 7.318489230769259}, {'text': 'to  June  6th).  There  were  signiﬁcantly  more  incidental  SARS-CoV-2', 'font_size': 7.38282500000003}, {'text': '1st', 'font_size': 5.810933333333348}, {'text': 'hospitalization during the re-opening period (2.6 versus 1.0). COVID-19 =', 'font_size': 7.47180000000003}, {'text': 'coronavirus disease-2019, SARS-CoV-2 = severe acute respiratory syndrome', 'font_size': 7.47180000000003}, {'text': 'coronavirus 2.', 'font_size': 7.47180000000003}, {'text': 'aims  to  collect  and  study  medical  record  data  on  persons', 'font_size': 8.96629999999999}, {'text': 'diagnosed with COVID-19.[4] Although the National COVID', 'font_size': 8.783269387755094}, {'text': 'Cohort Collaborative is a laudable undertaking, the quality of the', 'font_size': 8.96629999999999}, {'text': 'collected data will determine the utility of the database as well as', 'font_size': 8.96629999999999}, {'text': 'the external validity of ﬁndings from studies using the database.', 'font_size': 8.96629999999999}, {'text': 'We have concerns about the variability in data collection across', 'font_size': 8.96629999999999}, {'text': 'institutions  and  are  wary  of  coding  practices  that  do  not', 'font_size': 8.96629999999999}, {'text': 'distinguish asymptomatic patients from those hospitalized with', 'font_size': 8.96629999999999}, {'text': 'COVID-related  symptoms.  Here,  we  describe  our  experience', 'font_size': 8.96629999999999}, {'text': 'from our hospital in northern Nevada.', 'font_size': 8.96629999999999}, {'text': 'We  investigated  incidence  patterns  of  COVID-19  among', 'font_size': 8.96629999999999}, {'text': 'patients  in  our  808-bed  tertiary  referral  center  to  assess  the', 'font_size': 8.96629999999999}, {'text': 'distribution of patients who were admitted for COVID-19 versus', 'font_size': 8.96629999999999}, {'text': 'those with an incidental ﬁnding of COVID-19. We hypothesized', 'font_size': 8.96629999999999}, {'text': 'that universal testing of patients presenting to the emergency', 'font_size': 8.96629999999999}, {'text': 'department would result in a higher number of positive cases', 'font_size': 8.96629999999999}, {'text': 'among hospitalized patients. We further hypothesized that the', 'font_size': 8.96629999999999}, {'text': 'proportion of patients admitted with a diagnosis of COVID-19 –', 'font_size': 8.96629999999999}, {'text': 'with or without COVID-19-related symptoms – would increase', 'font_size': 8.96629999999999}, {'text': 'in tandem with the prevalence of the disease in the community.', 'font_size': 8.96629999999999}, {'text': 'The  increase  in  the  number  of  hospitalized  patients  with', 'font_size': 8.966300000000018}, {'text': 'positive SARS-CoV-2 tests  results can likely be attributed  to', 'font_size': 8.966300000000018}, {'text': 'rising  community  prevalence  in  the  setting  of', 'font_size': 8.966300000000018}, {'text': 'increased', 'font_size': 8.966300000000018}, {'text': 'admissions for non-COVID-19 complaints during the postlock-', 'font_size': 8.966300000000018}, {'text': 'down period; data show that emergency department visits were', 'font_size': 8.966300000000018}, {'text': 'markedly decreased during state and national lockdowns, likely', 'font_size': 8.966300000000018}, {'text': 'Table 1', 'font_size': 7.9702000000000055}, {'text': 'Cross-tabulation of COVID-19 hospitalization type with respect to', 'font_size': 7.9702000000000055}, {'text': 'the lockdown timeline. There was an association between the', 'font_size': 7.970200000000006}, {'text': 'timeline and hospitalization type (P-value for x2 test of association', 'font_size': 7.9702000000000055}, {'text': '<.001).', 'font_size': 7.970199999999991}, {'text': 'Timeline', 'font_size': 7.9702000000000055}, {'text': 'Lockdown', 'font_size': 7.970199999999991}, {'text': 'Re-opening', 'font_size': 7.970199999999991}, {'text': 'Row total', 'font_size': 7.970199999999991}, {'text': 'Type of COVID-19 hospitalization', 'font_size': 7.9702000000000055}, {'text': 'Incidental', 'font_size': 7.9702000000000055}, {'text': '4 (4.3%)', 'font_size': 7.970199999999991}, {'text': '26 (20.3%)', 'font_size': 7.970199999999991}, {'text': '30 (13.6%)', 'font_size': 7.970199999999991}, {'text': 'Symptomatic', 'font_size': 7.9702000000000055}, {'text': 'Row total', 'font_size': 7.9702000000000055}, {'text': '88 (95.7%)', 'font_size': 7.970199999999991}, {'text': '102 (79.7%)', 'font_size': 7.970199999999991}, {'text': '190 (86.4%)', 'font_size': 7.970199999999991}, {'text': '92 (100%)', 'font_size': 7.970199999999991}, {'text': '128 (100%)', 'font_size': 7.970199999999991}, {'text': '220 (100%)', 'font_size': 7.970199999999991}, {'text': 'COVID-19 = coronavirus disease-2019.', 'font_size': 6.973799999999997}]
[{'text': 'Antwi-Amoabeng et al. Medicine (2021) 100:35', 'font_size': 7.970199999999977}, {'text': 'Medicine', 'font_size': 7.970199999999977}, {'text': 'Author contributions', 'font_size': 9.464600000000019}, {'text': 'Conceptualization: Daniel Antwi-Amoabeng, Gurpreet Chahal,', 'font_size': 8.966299999999933}, {'text': 'Nageshwara Gullapalli.', 'font_size': 8.966299999999933}, {'text': 'Data curation: Daniel Antwi-Amoabeng, Sumaiya Mahboob,', 'font_size': 8.966299999999933}, {'text': 'Rudy Tedja.', 'font_size': 8.966299999999933}, {'text': 'Funding acquisition: Gurpreet Chahal.', 'font_size': 8.966299999999933}, {'text': 'Investigation: Daniel Antwi-Amoabeng, Bryce David Beutler,', 'font_size': 8.966299999999933}, {'text': 'Rudy Tedja, Farah Madhani-Lovely.', 'font_size': 8.966299999999933}, {'text': 'Methodology: Rudy Tedja.', 'font_size': 8.966299999999933}, {'text': 'Supervision: Chris Rowan.', 'font_size': 8.966299999999933}, {'text': 'Writing – original draft: Bryce David Beutler.', 'font_size': 8.966299999999936}, {'text': 'Writing – review & editing: Nageshwara Gullapalli.', 'font_size': 8.966299999999935}, {'text': '2020;19  May  2020,  www.deccanherald.com/national/scientists-raise-', 'font_size': 7.47180000000003}, {'text': 'questions-on-quality-of-covid-19-dataﬂaunted-by-centre-as-infections-soar-', 'font_size': 7.47180000000003}, {'text': '839141.html.', 'font_size': 7.47180000000003}, {'text': '[3] Ledford H, Van Noorden R. High-proﬁle coronavirus retractions raise', 'font_size': 7.47180000000003}, {'text': 'concerns about data oversight. Nature 2020;582:160.', 'font_size': 7.47180000000003}, {'text': '[4] Rubin R. NIH launches platform to serve as depository for COVID-19', 'font_size': 7.47180000000003}, {'text': 'medical data. JAMA 2020;324:326.', 'font_size': 7.47180000000003}, {'text': '[5] Czeisler MÉ, Marynak K, Clarke KEN, et al. Delay or avoidance of', 'font_size': 7.47180000000003}, {'text': 'medical care because of COVID-19-related concerns – United States, June', 'font_size': 7.47180000000003}, {'text': '2020. MMWR Morb Mortal Wkly Rep 2020;69:1250–7.', 'font_size': 7.47180000000003}, {'text': '[6] World Health Organization . ‘Emergency Use ICD Codes for COVID-19', 'font_size': 7.47180000000003}, {'text': 'Disease  Outbreak.  2020;World  Health  Organization,  22  May  2020,', 'font_size': 7.47180000000003}, {'text': 'www.who.int/classiﬁcations/icd/covid19/en/.', 'font_size': 7.47180000000003}, {'text': '[7] World Health Organization . International Statistical Classiﬁcation of', 'font_size': 7.47180000000003}, {'text': 'Diseases and Related Health Problems 10th Revision (ICD-10)-WHO', 'font_size': 7.47180000000003}, {'text': 'Version  for  2019.  2019;World  Health  Organization,  30  May  2020,', 'font_size': 7.47180000000003}, {'text': 'https://icd.who.int/browse10/2019/en#U07.1.', 'font_size': 7.47180000000003}, {'text': 'References', 'font_size': 9.464600000000019}, {'text': '[1] Peretti-Watel  P, Seror V, Cortaredona  S, et  al. A  future vaccination', 'font_size': 7.47180000000003}, {'text': 'campaign against COVID-19 at risk of vaccine hesitancy and politiciza-', 'font_size': 7.47180000000003}, {'text': 'tion. Lancet Infect Dis 2020;20:769–70.', 'font_size': 7.47180000000003}, {'text': '[2] Ray Kalyan. Scientists Raise Questions on Quality of COVID-19 Data', 'font_size': 7.47180000000003}, {'text': 'Flaunted by Centre as Infections Soar. Deccan Herald, DH News Service', 'font_size': 7.47180000000003}, {'text': '[8] Maugeri A, Barchitta M, Battiato S, Agodi A. Estimation of unreported', 'font_size': 7.47180000000003}, {'text': 'SARS-CoV-2  cases  in  Italy  using  a  susceptible-exposed-infectious-', 'font_size': 7.47180000000003}, {'text': 'recovered-dead model. J Glob Health 2020;10:21105.', 'font_size': 7.47180000000003}, {'text': '[9] Maugeri A, Barchitta M, Battiato S, Agodi A. Estimation of unreported', 'font_size': 7.47180000000003}, {'text': 'novel  coronavirus  (SARS-CoV-2)', 'font_size': 7.47180000000003}, {'text': 'infections  from  reported  deaths:', 'font_size': 7.47180000000003}, {'text': 'a  susceptible-exposed-infectious-recovered-dead  model.  J  Clin  Med', 'font_size': 7.47180000000003}, {'text': '2020;9:1350.', 'font_size': 7.47180000000003}, {'text': '4', 'font_size': 7.970199999999998}]





















from llama_index.core.schema import NodeWithScore, QueryBundle, TextNode
import pandas as pd
from llama_index.postprocessor.flag_embedding_reranker import (
    FlagEmbeddingReranker,
)
import numpy as np
import time


start_time = time.time()
reranker = FlagEmbeddingReranker(model="/mnt/mydisk/wangyz/Reranker-evaluation/Model_path/bge-reranker-large/", top_n=100)

# 指定CSV文件路径
csv_file_path = '/mnt/mydisk/wangyz/Research_agent/csv_download/merged_citations.csv'

# 读取CSV文件
df = pd.read_csv(csv_file_path)

# 确保'abstract'字段存在
if 'Abstract' in df.columns:
    # 将'abstract'字段的所有值存入一个列表中
    # 如果CSV文件中有多行数据，这将创建一个包含所有摘要的列表
    documents = df['Abstract'].tolist()

    
    # 打印结果
    #print(document)
else:
    print("The CSV file does not contain an 'abstract' column.")



nodes = [NodeWithScore(node=TextNode(text=doc)) for doc in documents]
query = "How do genetic variations in the APOE gene influence an individual's susceptibility to late-onset Alzheimer's disease, and what role do these variations play in the physiological mechanisms of the disease?"
query_bundle = QueryBundle(query_str=query)
ranked_nodes = reranker._postprocess_nodes(nodes, query_bundle)
for i, node in enumerate(ranked_nodes):
    print(node.node.get_content(), "-> Score:", node.score)

end_time = time.time()

print("花时：",end_time-start_time)#125s











from llama_index.core.schema import NodeWithScore, QueryBundle, TextNode, Node, Document
from llama_index.core import VectorStoreIndex, SimpleDirectoryReader
from llama_index.core.retrievers import VectorIndexRetriever
from llama_index.core.service_context import ServiceContext
import time
import pandas as pd
from langchain.embeddings import HuggingFaceBgeEmbeddings

start_time = time.time()
csv_file_path = '/mnt/mydisk/wangyz/Research_agent/csv_download/merged_citations.csv'
df = pd.read_csv(csv_file_path)
if 'Abstract' in df.columns:
    documents = df['Abstract'].tolist()
else:
    print("The CSV file does not contain an 'abstract' column.")
query = "How do genetic variations in the APOE gene influence an individual's susceptibility to late-onset Alzheimer's disease, and what role do these variations play in the physiological mechanisms of the disease?"
embed_model = HuggingFaceBgeEmbeddings(model_name="/mnt/mydisk/wangyz/Reranker-evaluation/Model_path/bge-embedding-large/" , model_kwargs={'device': 'cuda'} , encode_kwargs={'normalize_embeddings': True})

text_nodes = [TextNode(text=doc) for doc in documents]
service_context = ServiceContext.from_defaults(llm=None, embed_model=embed_model)

# 使用 ServiceContext 创建 VectorStoreIndex
vector_index = VectorStoreIndex(text_nodes,service_context=service_context)
vector_retriever = VectorIndexRetriever(index=vector_index, service_context=service_context, similarity_top_k=100)
retrieved_nodes = vector_retriever.retrieve(query)

# 打印出每个检索到的文档的文本和相似分数
print("Top 10 similar documents with their similarity scores:")
for node in retrieved_nodes:
    print(f"Document: {node.node.text}\nSimilarity Score: {node.score:.4f}")


end_time = time.time()
print("花时：",end_time-start_time)# 40s



vo = voyageai.Client()
# This will automatically use the environment variable VOYAGE_API_KEY.
# Alternatively, you can use vo = voyageai.Client(api_key="<your secret key>")

middle_index = len(documents) // 2
documents_part1 = documents[:middle_index]
documents_part2 = documents[middle_index:]

reranking_1 = vo.rerank(query, documents_part1, model="rerank-lite-1", top_k=50)
reranking_2 = vo.rerank(query, documents_part2, model="rerank-lite-1", top_k=50)
for r in reranking_1.results:
    print(f"Document: {r.document}")
    print(f"Relevance Score: {r.relevance_score}")

for r in reranking_2.results:
    print(f"Document: {r.document}")
    print(f"Relevance Score: {r.relevance_score}")



end_time = time.time()
print("花时：",end_time-start_time)# 5.36














import voyageai
import os
import time
import pandas as pd
import csv
import numpy as np
import requests
os.environ["VOYAGE_API_KEY"] = "pa-5C2ZvLnYfOYMIxzA8JD4k5jNn8gIIQIUxCOs5PpPJaE"
voyage_api_key = os.getenv('VOYAGE_API_KEY')


start_time = time.time()
csv_file_path = '/mnt/mydisk/wangyz/Research_agent/csv_download/merged_citations.csv'
df = pd.read_csv(csv_file_path)
if 'Abstract' in df.columns:
    documents = []
    for index, row in df.iterrows():
        title = row['Title'] if row['Title'] else 'No Title'
        abstract = row['Abstract'] if row['Abstract'] else 'No Abstract'
        documents.append(f"{title} {abstract}")
else:
    print("The CSV file does not contain an 'abstract' column.")
query = "How do genetic variations in the APOE gene influence an individual's susceptibility to late-onset Alzheimer's disease, and what role do these variations play in the physiological mechanisms of the disease?"




url = f"https://api.jina.ai/v1/rerank"

headers = {
    "Content-Type": "application/json",
    "Authorization": f"Bearer jina_6c29330db7c243f489e11a2eec22846eNUAZ3USPzUnHIi5tuJkDApnffTIE"
}

data = {
    "model": "jina-reranker-v1-base-en",
    "query": query,
    "documents": documents,
    "top_n": 100
}

response = requests.post(url, headers=headers, json=data)
print(response.json())


end_time = time.time()
print("花时：",end_time-start_time)# 9.02





#model = AutoModel.from_pretrained('/mnt/mydisk/wangyz/Reranker-evaluation/Model_path/bge-embedding-large') # trust_remote_code is needed to use the encode method
#embeddings = model.encoder(['How is the weather today?', 'What is the current weather like today?'])
import requests
import numpy as np
url = 'https://api.jina.ai/v1/embeddings'

headers = {
  'Content-Type': 'application/json',
  'Authorization': 'Bearer jina_d50f5435e6fe468aba2f8db9eedd55e9LfAD4w3ND12nWmbDj0A0VXpqKN_o'
}

data = {
  'input': ["How do genetic variations in the APOE gene influence an individual's susceptibility to late-onset Alzheimer's disease, and what role do these variations play in the physiological mechanisms of the disease?", "The e4 allele of the apolipoprotein E gene is the strongest genetic risk factor        for sporadic Alzheimer's disease. Nevertheless, how APOE is regulated is still        elusive. In a trans-eQTL analysis, we found a genome-wide significant association        between transmembrane protein 106B (TMEM106B) genetic variants and cortical APOE        mRNA levels in human brains. The goal of this study is to determine whether        TMEM106B is mis-regulated in Alzheimer's disease or in other neurodegenerative        conditions. Available genomic, transcriptomic and proteomic data from human        brains were downloaded from the Mayo Clinic Brain Bank and the Religious Orders        Study and Memory and Aging Project. An in-house mouse model of the hippocampal        deafferentation/reinnervation was achieved via a stereotaxic lesioning surgery to        the entorhinal cortex, and mRNA levels were measured using RNAseq technology. In        human temporal cortices, the mean TMEM106B expression was significantly higher in        Alzheimer's disease compared to cognitively unimpaired individuals. In the mouse        model, hippocampal Tmem106b reached maximum levels during the early phase of        reinnervation. These results suggest an active response to tissue damage that is        consistent with compensatory synaptic and terminal remodeling."],
  'model': 'jina-embeddings-v2-base-en'
}

response = requests.post(url, headers=headers, json=data)
print(response.json())
json_data = response.json()
embedding_1 = np.array(json_data["data"][0]["embedding"])
embedding_2 = np.array(json_data["data"][1]["embedding"])

# 计算余弦相似度
cosine_similarity = np.dot(embedding_1, embedding_2) / (np.linalg.norm(embedding_1) * np.linalg.norm(embedding_2))

print(f"Cosine similarity: {cosine_similarity}")














import concurrent.futures
from semantic_api import *
from impact_factor.core import Factor
from Rerank import *
from semantic_api import *
import voyageai
import os
import time
import pandas as pd
import csv
import numpy as np
import requests
import time
from scipy.stats import rankdata
from impact_factor.core import Factor


ip_api_url = "http://zhuoyuekeji.zhuoyuejituan.com:66/SML.aspx?action=GetIP&OrderNumber=49aaa3d6f86cfdd65477f2d387677f37&Split=&Address=&isp=&poolnumber=0&qty=1"


df_origi = pd.read_csv('/mnt/mydisk/wangyz/Research_agent/csv_download/PMC4234692_references.csv')
origi_references_list = df_origi['Semantic Scholar ID'].tolist()
rerank_citation_df = pd.read_csv('/mnt/mydisk/wangyz/Research_agent/csv_download/reranked_citation.csv')



proxies = []
max_workers = len(rerank_citation_df['Semantic Scholar ID'])//10
for i in range(max_workers):
    response = requests.get(ip_api_url)
    ip = response.text.strip()  # 去除末尾的多余字符
    proxies.append({"HTTP": f"HTTP://{ip}", "HTTPS": f"HTTP://{ip}"})
    print(f"添加代理: {ip}")

# 设置URL和请求头
headers = {
    'Connection': 'close'  # 设置为关闭长连接
}
session = requests.Session()




block4_start_time = time.time()

futures = {}
similarity_results = {}
impact_factor_results = {}
cited_number_results = {}

# 创建两个线程池
with concurrent.futures.ThreadPoolExecutor(max_workers=max_workers) as executor1, \
     concurrent.futures.ThreadPoolExecutor(max_workers=max_workers) as executor2:

    # 提交 get_similarity 任务
    for i, paperid in enumerate(rerank_citation_df['Semantic Scholar ID']):
        proxy = proxies[i % len(proxies)]  # 通过 Semantic Scholar ID 对代理列表进行轮询
        future = executor1.submit(get_similarity, session, paperid, origi_references_list, proxy)
        futures[future] = paperid  # 存储 future 和 paperid 的映射

    # 提交 impact_factor 任务
    for journal_id in rerank_citation_df['Journal_id'].unique():  # 确保对每个 journal_id 只计算一次
        future = executor2.submit(impact_factor, str(journal_id))
        futures[future] = journal_id

    # 收集 get_similarity 的结果
    for future in concurrent.futures.as_completed(futures):
        try:
            result = future.result()
            if result is not None:  # 确保返回的结果不是 None
                if futures[future] in rerank_citation_df['Semantic Scholar ID'].values:
                    similarity_results[futures[future]] = result[1]  # 假设 result 是一个元组 (similarity, cited_number)
                    cited_number_results[futures[future]] = result[2]
                elif futures[future] in rerank_citation_df['Journal_id'].values:
                    impact_factor_results[futures[future]] = result
        except Exception as e:
            print(f"Error: {e}")

# 更新 rerank_citation_df DataFrame，添加 similarity 和 impact_factor 列
if similarity_results:
    rerank_citation_df['similarity'] = rerank_citation_df['Semantic Scholar ID'].map(similarity_results)

if cited_number_results:
    rerank_citation_df['citednumber'] = rerank_citation_df['Semantic Scholar ID'].map(cited_number_results)

if impact_factor_results:
    rerank_citation_df['impact_factor'] = rerank_citation_df['Journal_id'].map(impact_factor_results)


rerank_citation_df.to_csv('/mnt/mydisk/wangyz/Research_agent/csv_download/test.csv', index=False)


block4_end_time = time.time()
print("Both similarity and impact factor calculations are complete.")
print("Time taken for this process:", block4_end_time - block4_start_time)





"""





